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Abstract
Despite the Centers for Disease Control and Prevention recommendations to test patients
ages 13 to 64 years for HIV at health care settings, routine HIV testing is lacking. As a
result, many people are unaware of their HIV seropositive status. The purpose of this
quantitative cross-sectional study was to examine relationships between HIV testing and
provider type, knowledge, attitudes, and behaviors regarding HIV testing in the acute
care setting. The study was informed by social cognitive theory. Using a convenient
sampling method, a questionnaire derived from previous surveys (Society of General
Internal Medicine and University of Washington) was sent to 600 eligible acute care
providers from a suburban Chicago hospital who treated HIV-negative patients ages 13 to
64 years. Completed surveys were received from 88 participants. Chi-square and multiple
logistic regression testing showed no significant relationships between HIV testing and
provider type (p = .09), age (p = .91), gender (p = .84), experience (p = 1), and
race/ethnicity. However, knowledge of HIV testing regulations and positive attitudes
about HIV testing were significantly associated with the likelihood of offering an HIV
test (p = .026, p = .004 respectively). Results have some clinical importance, but also
indicated a lack of routine opt-out HIV testing. Results may be used to promote HIV
testing among acute care providers which could reduce HIV-status unawareness in the
population.
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Chapter 1: Introduction to the Study
The HIV/AIDS epidemic continues to affect people all over the world in many
ways, and it remains a global public health challenge. Since its emergence, HIV/AIDS
has resulted in an estimated 34 million deaths globally, and 1.2 million people died from
HIV-related complications in 2014 (World Health Organization [WHO], 2015). About
36.9 million people were living with HIV infections in 2014, 2.0 million people became
newly infected with HIV infection in the same period, and approximately 51% of people
were unaware they were infected with HIV (WHO, 2015). In the United States, there
were about 1.2 million people living with HIV in 2012, and 28.2% lacked knowledge of
being infected (CDC, 2015a). According to a study based on the National Health and
Nutrition Examination Survey (NHANES), about 50% of the people infected with HIV in
the United States are not under medical care due to lack of seropositive awareness
(Woodring, Kruszon-Moran, & McQuillan, 2015). HIV works by attacking and gradually
impairing the immune system, thereby rendering a person incapable of fighting off
common ailments (U.S. Department of Health and Human Services, 2015). With a
weaker immune system, people infected with HIV are also susceptible to certain medical
conditions and cancers. Thus far, there is no cure for HIV infection; however, with the
introduction of highly active antiretroviral therapy (HAART), people who are infected
with HIV can live longer and healthier lives (Deeks, Lewin, & Havlir, 2013). This is the
basis for the need to increase HIV screening and testing efforts to facilitate timely HIV
diagnosis, a measure that gives affected individuals the opportunity for early entry into
treatment modalities. This study was needed because HIV testing is not widely
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implemented and is not routinely offered even within the health care settings despite
recommendations from several agencies such as the CDC and the U.S. Preventive
Services Task Force (USPSTF) (Anaya et al., 2012; Arbelaez et al., 2012; Egan et al.,
2010; Herrin et al., 2013; Tai & Merchant, 2014) The studies that addressed the impact of
provider characteristics and provider type on HIV testing among acute care providers
indicated inconclusive outcomes. The social change implications for this study are the
potential to increase HIV testing in acute care settings, to raise awareness of the need to
increase efforts to promote broader HIV screening and testing, and to mitigate HIV
transmissions. This chapter includes the background, purpose, problem statement,
significance, definitions, theoretical basis, assumptions, and limitations of the study.
Background of the Problem
Infection with HIV/AIDS continues to exert a considerable health and economic
burden across the globe, especially in the United States where it remains a great public
health concern. HIV was first noted in 1981 following mysterious sicknesses and deaths
of young gay men who had developed a rare case of Pneumocystis carinii pneumonia in
Los Angeles, California (Mortality and Morbidity Weekly Report [MMWR], 1981).
Since its emergence, HIV/AIDS has resulted in the deaths of approximately 34 million
people globally, including about 1.2 million deaths in 2014 (WHO, 2015). There were
about 1.2 million people in the United States who were infected with HIV in 2012, and
one in seven lacked knowledge of being infected (CDC, 2013). The number of new HIV
infections has remained steady at about 50,000 per year since the 1990s (CDC, 2012;
Hall et al., 2008). There is significant mortality and morbidity associated with
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HIV/AIDS, but both have steadily declined since the introduction of HAART (CDC,
2015; Crum et al., 2006). Even though the rate of HIV infection has declined among U.S
residents, the overall incidence of HIV infections remains at an unacceptable level (CDC,
2012; Hall et al., 2008, Woodring et al., 2015). In addition, HIV prevalence is more
pronounced among minority populations.
Prevention of HIV infection is dependent upon people abstaining from risky
sexual behaviors, and an increase in HIV awareness among those who might be infected.
Too many people remain unaware of being infected with HIV, which increases the risk of
others contracting HIV (Schnall et al., 2013). The latest estimate from the WHO (2015) is
that about 51% of people infected with HIV do not know their serostatus. Between 14%
and 20% of those infected with HIV in the United States are unaware of their infection
(CDC, 2013; Schnall et al., 2013). A multicity study indicated that almost half of HIVpositive young men who had sex with men (MSM) were unaware of being infected with
HIV, and another 27% had not been tested in the previous year as recommended by the
CDC (2013). Furthermore, Clauss et al. (2011) found that as many as 29% of HIVinfected patients who visited emergency departments (ED) were unaware that they had
HIV infection. Another study indicated that as many as 74.9% of patients who visited ED
in 2011 were not aware of their HIV status (Felsen, Bellin, Cunningham, & Zingman,
2015). The exact estimates of the prevalence of HIV unawareness in the ED is difficult to
pinpoint. What research shows, however, is that a significant number of people who
utilize ED services may have HIV infection but lack the awareness. The persistent lack of
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awareness of seropositive status continues to negatively impact HIV prevention
measures, making this an area that would benefit from further research.
Personal knowledge of HIV status requires that individuals undergo HIV testing.
There are many venues where HIV testing services are offered, and many of these venues
offer free testing. HIV testing first became available in 1985 when the Food and Drug
Administration (FDA) licensed a test that detects HIV antibodies in the blood. As the
technology to detect serum HIV became available, recommendations for HIV testing
evolved. In 1987, the U. S. Public Health Service (USPHS) issued recommendations
mandating that people who engaged in risky sexual behaviors, those with heightened risk
for contracting HIV infection, and those seeking treatments for sexually transmitted
diseases (STDs) be tested for HIV (MMWR, 1987). The CDC issued guidelines in 1993
expanding voluntary HIV testing and counseling to include health care settings such as
hospitals, emergency departments, and outpatient clinics (MMWR, 1993). In 2001, the
CDC added to the HIV testing recommendations by encouraging prenatal screening for
HIV in all pregnant women, and expanded HIV testing to include all patients in private
and public health care centers (MMWR, 2001). The CDC again revised HIV testing
guidelines in 2003 by making HIV testing a routine yet voluntary part of medical care,
and added universal HIV testing for all pregnant women during labor, delivery, and
postpartum periods (MMWR, 2003). The CDC made additional changes in 2006 with the
aim of making HIV testing more available and accessible; the new recommendations
eliminated the pre- and posttest counselling requirements and the written consent for HIV
testing, but called for nontargeted opt-out HIV testing in all health care settings (Branson
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et al., 2006). Other private organizations such as the American College of Emergency
Physicians (ACEP) also adopted the CDC guidelines and encouraged broad-based HIV
testing among its members (ACEP, 2014). The 2006 HIV testing recommendations were
aimed at all health care facilities and specified that all patients 13 to 64 years old be
offered HIV testing unless they opt out, especially in areas where the local HIV
prevalence is ≥ 0.1. In Cook County, IL, the local HIV prevalence based on 2013 data
was 2.6, whereas that of Will County was 0.3 (Illinois Department of Public Health
[IDPH], 2013). Both counties, especially the study site Will County, exceeded the
recommended threshold for routine HIV testing. Among U.S. states, Illinois was ranked
8th regarding reported number of diagnosed HIV cases during 2013 (CDC, 2015b).
Despite the CDC recommendations, many patients who visited the ED were not aware
that HIV testing was available and that it would be performed quickly with subsequent
release of results before discharge (Aronson et al., 2015). Moreover, many people
received an AIDS diagnosis the first time they received HIV testing but had several prior
encounters with health care providers for routine medical care, although they were not
advised to have HIV screening before (Liddicoat et al., 2004; Nakao, Wiener, Newman,
Sharp, & Egan, 2014). Delayed HIV testing denies patients infected with HIV the
opportunity to access effective treatment modalities, impairs patients’ quality of life, and
increases the economic burden associated with AIDS-related morbidity.
There are several barriers that impede routine HIV testing in the acute care
setting: HIV stigma; lack of HIV knowledge; discomfort discussing sexual matters; and
attitudes, beliefs, and perceptions of low HIV transmission risk (Hunter, Perry, Leen, &

6
Premchand, 2012; Kinsler, Sayles, Cunningham, & Mahajan, 2013; Korthuis et al., 2011;
Lanier et al., 2014). HIV testing barriers linked to providers include time constraint, lack
of reimbursement, the lengthy process of referral and linkage to care for the infected
patients, lack of HIV testing guidelines knowledge, attitudes toward HIV testing, and
competing ED responsibilities (Anaya et al., 2012; Arbelaez et al., 2012; Egan et al.,
2013; Levison, Williams, Moore, McFarlane, & Davila, 2012). In addition, there are
structural barriers such as lack of adequate resources, staffing, and HIV screening
programs (Egan et al., 2014; Houkoos et al., 2013). Although there are several barriers
that hinder the uptake of HIV testing particularly in acute care settings and EDs,
variability in the implementation of HIV testing among health care providers might be
contributing to the low rates of HIV testing (Walensky et al., 2011). Examining how
unique provider characteristics, behaviors, and attitudes impact HIV testing in the acute
care setting might reveal areas of weakness that could help policy experts and clinical
administrators identify effective measures to improve HIV testing.
Although the CDC recommends nontargeted opt-out HIV testing in all patients
ages 13 to 64 years in health care settings, many providers continue to conduct targeted
HIV testing in their practices (Christopoulos et al., 2011; Lubelcheck et al., 2011;
Schrantz et al., 2011). One challenge associated with targeted HIV testing is the selfperception of low HIV risk among ED patients, which leads patients to hold back from
disclosing information about behaviors that are relevant to HIV infection; as a result,
providers fail to see the need for offering an HIV test (Pringle, Merchant, & Clark, 2013).
The targeted HIV testing approach may result in missed opportunities for testing,
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especially among ED patients who have shown a tendency to be late testers despite
having prior ED encounters (Nakao et al., 2014). Researchers observed that some
providers were in favor of the current HIV testing guidelines, but other providers
demonstrated opposition to the guidelines (Merchant et al., 2012; Nassry et al., 2012).
Other providers believe that HIV testing takes precious time away from essential ED
services, and therefore should be relegated to different venues (Sison et al., 2013).
Providers who have favorable attitudes toward HIV testing are more likely to support
ED-based HIV testing (Berkenblit et al., 2012). Berkenblit et al. (2012) also found that
beliefs among providers that the local HIV prevalence is low resulted in those providers
being less likely to offer HIV testing. However, Akhter, Gorelick, and Beckmann (2012)
found that local HIV prevalence had no influence on HIV testing rates among providers.
Knowledge of HIV testing guidelines among many providers was noted to be
considerably low (Arya et al., 2014; Hunter et al., 2012; Levison et al., 2012). When
training was offered to promote awareness of HIV testing guidelines and processes, some
providers were supportive and improved their test offering (Lanier et al., 2014; Meanley
et al., 2015), while other providers were partially supportive or neutral toward HIV
testing (Arbelaez et al., 2012).
Providers’ characteristics such as age, race/ethnicity, gender, years of experience,
and provider type might exert some influence on HIV testing. Bares et al. (2012) found
that few ED pediatricians, obstetrics/gynecology physicians, and internal medicine
providers adhered to the recommended HIV testing guidelines, while McNaghten et al.
(2013) found that family or general practitioners had higher rates of offering HIV testing

8
than emergency medicine, internal medicine, and pediatric providers. Akhter et al. (2012)
noted that ED pediatricians who scored higher in the self-efficacy scale offered more
HIV tests to their patients. When providers’ gender was considered, most researchers
observed that not only were female providers more likely to offer HIV testing, but they
also had higher percentages of their patients agreeing to have the HIV test (Arbelaez et
al., 2012; Bernstein, Begier, Burke, Karpti, & Hogben, 2008; Hsieh et al., 2009).
Bernstein et al. (2008) noted that in an ED setting there were no gender differences in the
rate of HIV testing. The effect of providers’ years of work experience on HIV testing has
not been adequately studied. One study addressed this variable in residents who worked
in ED (Hsieh et al., 2009), and an Australian study addressed this variable among those
working in HIV/AIDS-based clinics (Conway et al., 2015). There has been little work
done on the impact of providers’ age on HIV testing in ED. Bernstein et al. (2008) and
McNaghten et al. (2013) noted that providers 40 years old and younger were more likely
to offer HIV testing compared to older providers. In terms of race/ethnicity, African
American and Hispanic providers were more likely to offer HIV testing especially in
clinic settings (Bernstein et al., 2008; McNaghten et al., 2013), but the impact of
race/ethnicity on HIV testing in ED has not been studied. When considering provider
type and HIV testing, researchers in one study found nurse practitioners (NPs) were more
likely to offer HIV testing than medical doctors (MDs) (Fincher-Mergi et al., 2002;
McNaghten et al., 2013), in another study researchers indicated that NPs and physician
assistants (PAs) were less likely to offer HIV testing than MDs (Bender Ignacio et al.,
2014). The relationship between provider type and HIV testing in the acute care setting is
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understudied and represents a gap in the current literature (Bender Ignacio et al., 2014;
McNaghten et al., 2013; Wilson et al., 2005). This study was needed to investigate the
extent to which provider type and characteristics impact HIV testing in the acute care
setting. Knowledge from this study may assist in the implementation of programmatic
and practice changes within the acute care setting that may increase HIV testing, which
could lead to fewer cases of unknown status of HIV infection and mitigate the
transmission of HIV.
Problem Statement
The relationships between HIV testing and provider type and providers’
knowledge, attitudes, and behaviors about HIV testing in the acute care setting are
understudied. Additionally, the influence of provider-identified barriers to HIV testing in
the acute care setting merits further study. The benefits of access to timely HIV testing
and diagnosis have been well documented in the literature. Chief among these is the
initiation of treatment at the most opportune time and the reduction in the percentage of
persons who lack knowledge of their seropositive status. This lack of knowledge
regarding seropositive status is at the root of continued HIV transmissions (Clauss et al.,
2011; Schnall et al., 2013). Routine HIV testing is underutilized in the acute care setting
despite existing recommendations (Anaya et al., 2012; Arbelaez et al., 2012; Egan et al.,
2010; Herrin et al., 2013; Tai & Merchant, 2014). Lack of routine HIV testing in the
acute care settings has resulted in many people being diagnosed with HIV infection in
later stages of the illness (CDC, 2013; Liddicoat et al., 2004). In the United States, only
50% of those infected with HIV are on antiretroviral therapy (Woodring et al., 2015), and
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only 30% of HIV-infected individuals on antiretroviral therapy have achieved viral
suppression (CDC, 2014c). Most HIV-infected individuals currently not undergoing
HAART treatment are doing so because they have never been diagnosed (Woodring et
al., 2015). Because of failure to receive treatment and inability to achieve viral
suppression, HIV-infected individuals will continue to spread the disease to others (Chen
et al., 2012; Mark, Crepaz, Senterfitt, & Janssen, 2005). Several barriers hinder routine
HIV testing in the acute care settings, and some of these barriers, such as lack of
reimbursement, time constraints, low staffing, lack of self-efficacy, referral requirements,
and lack of knowledge of HIV testing guidelines, are associated with the health care
providers (Anaya et al., 2012; Arbelaez et al., 2012; Egan et al., 2013; Levison et al.,
2012). Providers’ attitudes toward HIV testing is also linked to the offering of HIV
testing (Berkenblit et al., 2012; Sison et al., 2013). Several provider characteristics,
including age, gender, race/ethnicity, and years of work experience, are worthy of
examination as they may be directly influencing the performance of HIV testing in the
acute care setting. Previous research has indicated mixed results on the influence of
provider characteristics on HIV testing in the acute care setting (Arbelaez et al., 2012;
Bernstein et al., 2008; Hsieh et al., 2009; McNaghten et al., 2013). Furthermore, the
extent to which the type of provider impacts HIV testing in acute care settings is
unknown (Akhter et al., 2012; Bares et al., 2012; Fincher-Mergi et al., 2002; McNaghten
et al., 2013). It was therefore necessary to determine the impact of these variables on HIV
testing in the acute care setting, because increased HIV testing and serostatus awareness
are relevant to the goal of reducing HIV transmission
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The CDC in 2006 issued HIV testing recommendations encouraging and
promoting routine opt-out HIV testing in all patients aged 13 to 64 years. The State of
Illinois, following the CDC recommendations, revised its HIV testing regulations and
removed burdensome HIV testing requirements such as a written consent, making it
easier for providers to conduct HIV testing. Nevertheless, the prevalence of HIV/AIDS in
Illinois, especially in the Chicago area, has remained high compared to the national
average (CDPH, 2014). Many programs targeting HIV-infected individuals have been
established by both private and government agencies in the United States. In addition,
there have been improvements in the drugs utilized for HIV/AIDS management and the
approval of a pre-exposure prophylaxis regimen. However, the benefits associated with
these therapeutic programs and treatment regimens are limited by the number of people
who are unaware of being infected with HIV. A major hospital within a large network of
hospitals in the southwestern suburbs of Chicago, IL was the setting for this study.
Located in Will County, this hospital serves many patients who come from an area with
HIV prevalence greater than the 0.1% established by the CDC as the threshold for routine
HIV testing. However, it was not known whether providers from this region consider the
area’s HIV prevalence when offering HIV testing in the acute care setting. It was also not
known whether the lack of HIV testing regulations, provider behaviors, and attitudes
toward HIV testing play a role in HIV testing rate in this area. Furthermore, there was no
consensus on how provider type and characteristics in this area impact overall HIV
testing in the acute care setting. An examination of these issues was needed, and more
research may result in the reduction of barriers to HIV testing, which could lead to the
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reduction of persons unaware of being infected with HIV and the prevention of
HIV/AIDS in this area and elsewhere.
Purpose of the Study
The purpose of this quantitative study was to examine the relationships between
HIV testing and providers’ type, knowledge, attitudes, and behaviors with respect to HIV
testing in the acute care setting. This study addressed the relationship between provideridentified barriers to HIV testing and HIV testing in the acute care setting. Current HIV
screening, testing, and prevention initiatives have not succeeded in eliminating
HIV/AIDS. There are more than 1.2 million people living with HIV infection in the
United States, including 12.8% who are unaware of being infected with HIV (CDC,
2015c). Additionally, about 50,000 people are diagnosed annually with HIV infection in
the United States, and almost 14,000 people die annually from AIDS-related
complications (CDC, 2015c). Knowledge gained from this study could inform HIV
testing practices in the acute care setting, and this may lead to an increased number of
people being aware of their HIV status through increased testing. Improving the rate of
HIV testing, especially within the acute care setting, requires overcoming existing
provider-identified barriers. A reduction of HIV infection depends on increasing the HIV
testing rate, which has potential to lower the risk of HIV transmissions. This study
included a cross-sectional design and primary data collected using a survey questionnaire.
The dependent variable was HIV testing, and the independent variables were providers’
type, age, gender, race/ethnicity, HIV testing behaviors, attitude towards HIV testing, and
years of work-related experience.
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Research Questions and Hypotheses
Research Question 1: What is the relationship between HIV testing and provider
type (nurse practitioner [NP], physician assistant [PA], physician [MD]) in the acute care
setting?
H01: There is no relationship between HIV testing and provider type (nurse
practitioner [NP], physician assistant [PA], physician [MD]) in the acute care setting.
Ha1: There is a relationship between HIV testing and provider type (nurse
practitioner [NP], physician assistant [PA], physician [MD]) in the acute care setting.
Research Question 2: What is the relationship between HIV testing and providers’
knowledge, attitudes, and behaviors with respect to HIV testing in the acute care setting?
H02: There is no relationship between HIV testing and providers’ knowledge,
attitudes, and behaviors with respect to HIV testing in the acute care setting.
Ha2: There is a relationship between HIV testing and providers’ knowledge,
attitudes, and behaviors with respect to HIV testing in the acute care setting.
Research Question 3: Is there a relationship between HIV testing and provideridentified barriers to it in the acute care setting?
H03: There is no relationship between HIV testing and provider-identified barriers
to it in the acute care setting.
Ha3: There is a relationship between HIV testing and provider-identified barriers
to it in the acute care setting.
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Theoretical Framework
The National HIV/IDS Strategy (NHAS) is a national program that was
implemented with specific goals including mitigating HIV infections, making HIV
treatment accessible to all, and eliminating healthcare discrimination associated with HIV
infection (Office of National AIDS Policy, 2010). One process that may help to realize
these goals is routine HIV testing in all healthcare settings. Universal HIV screening
could reduce the number of people who are infected with HIV but lack this critical
knowledge. A timely diagnosis of HIV infection could also enable affected individuals to
access life-prolonging therapies, which could improve their quality of life by halting the
development of AIDS. This study included concepts from social cognitive theory (SCT)
established by Miller and Dollard (1941) and advanced by Bandura (1977). The SCT
proposes that human behavior is a product of complex interactions between
environmental, personal, and behavioral forces (Glanz, Rimer, & Viswanath, 2008). This
framework is essential for examining how behavior is learned and maintained in group
and individual settings, as well as delineating capacity and motivation for learning new
behavior. The SCT is a theoretical framework that has been widely applied in social
science research, especially in the study of health-related behaviors. The integration of
the SCT in this study could aid in examining the degree to which providers’
characteristics, attitudes, practice settings, and HIV testing behaviors impact HIV testing
in the acute care setting. Moreover, the SCT provides a framework for designing and
implementing new interventions as well as evaluating existing programs related to HIV
testing. More importantly, the overarching concept that individuals have the capacity to
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alter their surrounding environment to achieve desired goals (Glanz et al., 2008) is key to
examining the role of providers and the impact of existing barriers to HIV testing in the
acute care setting. The theoretical framework is discussed in more detail in Chapter 2.
Nature of the Study
This study was quantitative and included a cross-sectional design. The crosssectional design was appropriate because it allowed me to examine the current state of
HIV testing in the acute care setting, and determine how providers influenced the rate of
HIV testing in the target location. Also, the cross-sectional design is commonly used by
researchers to delineate the prevalence of target outcomes and to examine how specific
variables interact to create current events (Carlson & Morrison, 2009). The crosssectional design is convenient, cost-effective, timely, and easy to attain a large sample
size.
The relationships between HIV testing in the acute care setting and providers’
characteristics (age, gender, race/ethnicity, years of experience), knowledge of testing
regulations, attitudes toward HIV testing, testing behaviors, and practice setting was
examined using multiple logistic regression. In addition, I examined how provideridentified barriers interact to influence HIV testing in various practice settings as well as
among different provider types. Data for this study were obtained using a survey
questionnaire sent to all eligible health care providers at a local hospital in suburban
Chicago. After data were collected, data analysis was performed using IBM SPSS
software. The dependent variable was HIV testing, and the independent variables were
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providers’ type, age, gender, race/ethnicity, attitude towards HIV testing, HIV testing
behaviors, and years of work experience.
Definitions of Terms
AIDS: Acquired immunodeficiency syndrome caused by the HIV (Last,
2001).
HAART (highly active antiretroviral therapy): Preferred HIV treatment protocol
that combines three drugs to stop viral replication and resistance (WHO, 2015b).
ED population: Individuals who visit emergency departments in a defined period
(Lyons et al., 2008).
ED environment: General ED infrastructure including demographics, size,
affiliations, mission, HIV testing programs or prevention focus, and residency if available
(Lyons et al., 2008).
Late diagnosis: With regards to HIV testing, the presence of opportunistic illness
at presentation or development of such illness within a year, or having a CD4 count of
less than 200cells/μL at presentation or within 90 days (Lyons et al., 2008).
Serostatus: Negative or positive reactivity to an antigen in the blood such as HIV
(National Institute of Health [NIH], 2015a).
Seropositive: The state of having detectable antibodies to HIV (NIH, 2015a).
Seronegative: Absence of detectable HIV antibodies (NIH, 2015a).
Seroprevalence: In relation to HIV, the number of people with serologic evidence
of HIV antibodies in a defined population (NIH, 2015a).
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Rapid HIV test: HIV testing that is done using blood or oral fluid for antibody
detection whereby results are available within 30 minutes. A confirmatory test, often with
Western Blot, is required on every positive rapid HIV test (NIH, 2015a).
Reciprocal determinism: The concept that people’s behaviors can influence and
be influenced by personal factors and environmental forces (Bandura, 1986).
Triadic reciprocality: The way that people learn behaviors or new skills that is
attributed to the influence of personal, behavioral, and environmental factors (Bandura,
1986).
Collective efficacy: Actions taken by a group of individuals with common goals,
who utilize group inertia and capacity to achieve better outcomes (Bandura, 1986).
Incentive/motivation: Factors and experiences that influence people’s behaviors,
especially those geared toward obtaining certain rewards (Bandura, 1986)
Assumptions
This study included quantitative methods to examine the phenomenon of HIV
testing in the acute care setting and the influence of providers on the rate of HIV testing.
The quantitative approach involves the assumption that reality is singular and can be
measured objectively without the interference of the researcher, and that research
generated using this method can be replicated and generalized (Creswell, 2009). The
utility of the quantitative approach is well established in the research community, and it
has been widely used by researchers over the years with good results. I also assumed that
study participants would be honest in answering research questions and the information
they provided would indicate an accurate measure of their performance with respect to
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HIV testing. I worked under the assumption that the number of people unaware of being
infected with HIV is as reported. The actual number of people who are infected with HIV
but lack the knowledge of being seropositive is difficult to obtain. The CDC (2015c)
estimated that each year about 50,000 people are newly diagnosed with HIV in the
United States, and one in seven are unaware of being infected. Other researchers have
discovered higher rates of HIV infection unawareness among patients who visited EDs.
Lack of knowledge of seropositive status is derived from the comparison of actual HIV
serology results and what patients believed to be their HIV status (Sanchez et al., 2014).
However, this system of estimating HIV infection unawareness is not very accurate due
to the possibility of errors in self-report.
Increased HIV testing and screening is likely to increase the number of people
with HIV infection who know their seropositive status, which may decrease the
transmission rate and lower the incidence of HIV infections. I assumed that people who
learned of their HIV infection would pursue appropriate care and counseling, and more
importantly, would alter their risky behaviors and seek treatment promptly. Lack of
awareness of being infected with HIV is linked to late HIV diagnosis (AIDS); delayed
entry into therapeutic programs such as counseling, housing assistance, medical
coverage, and assistance with prescription drugs; and missed opportunities for lifeprolonging HAART.
Scope and Delimitations
Scope
This study relied on data obtained from acute care and ED providers to examine
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the impact of provider characteristics on HIV testing. Providers who treat patients in
psychiatric units and medical residents were excluded from this study. Acute care
providers have the authority and discretion to conduct HIV testing. Despite the
recommendations for HIV testing, providers often use their judgment and discretion with
respect to ordering HIV testing; therefore, the focus of this study was the effect of acute
care providers on HIV testing.
Delimitations
The purpose of this study was to examine the relationships between HIV testing
in the acute care setting and provider type, knowledge, attitudes, and beliefs with respect
to HIV testing. This study, however, was not intended to examine all types of providers
in all settings, as this would not have been feasible. I considered using data solely from
the medical records, but this was rejected due to the burden of IRB approval and the risks
involved in dealing with personal health information (PHI). I focused on hospital and
ED-based providers and excluded patients from different settings. This study was limited
to the variables and information obtained using a specific questionnaire and providers’
self-report. Secondly, the cross-sectional design imposed a limitation on the study.
Furthermore, the choice of the study problem was yet another delimiting decision as it
pointed to the possibility of other similar problems that would have been selected but
were dismissed. Because this study focused on participants in a unique setting, its
potential for generalizability was limited.
There are two theories that were closely evaluated to be used in this study, but
they were rejected. First, I considered the theory of planned behavior (TPB), which
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focuses mainly on the role of attitude and intention on behavior change (Glanz et al.,
2008). However, it was narrow and would not have fully addressed most of the factors
that drive the testing of HIV in the acute care setting. Second, I considered the health
behavior model (HBM), but it is more appropriate in explaining why patients fail to seek
HIV testing rather than why providers fail to offer HIV testing. Although some concepts
of the HBM, such as perceived barriers, perceived benefits, and self-efficacy, were
relevant to the current study, the HBM lacked concrete concepts to account for
environmental factors that preclude HIV testing in the acute care setting (see Glanz et al.,
2008).
Limitations
The first limitation was related to the study design. The cross-sectional design
cannot be used to establish causation. Another limitation was that it may not be possible
to generalize the findings to other populations in different regions due to the design and
sampling limitations. Furthermore, the survey questionnaire limited participants’
perspectives to the extent that their responses could only fall within certain parameters.
Self-report was another limitation that may have impacted internal validity. Additionally,
it was possible that respondents were those who cared more about or had more exposure
to the subject matter. Therefore, the sample may not have been truly representative. Lack
of incentives to participate, especially among busy professionals, may have limited the
number of respondents including those whose contributions might have influenced this
study’s results.
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There were possible measures to mitigate the limitations. First, a cohort study
design might have been better at establishing temporality, even though it could not
establish causality. Second, giving incentives to participants might have resulted in a
higher response rate and perhaps better representation. Third, including other acute care
providers such as nurses and administrators might have yielded more accurate
determination of the state of HIV testing in the acute care setting.
Significance of the Study
Despite availability of effective treatment modalities against HIV infection,
morbidity and mortality associated with HIV/AIDS continue to burden many regions of
the world, including the United States. Given that many people infected with HIV remain
unaware of their serostatus and thus are precluded from capitalizing on life-prolonging
antiretroviral drugs and are more likely to transmit HIV, more measures are needed to
increase HIV testing and prevent HIV transmission. HIV infection is a preventable
disease; however, once contracted, there is no cure. Therefore, it is important to find
ways to enhance HIV testing in all venues and to promote the reduction of risky sexual
behaviors among people with known HIV risk profiles.
The study findings could help to determine the impact of acute care and ED
providers on the rate of HIV testing among patients who utilize their services. It is crucial
to find new ways of increasing HIV testing in the acute care setting and other settings, as
recommended by the CDC. The findings from this study could contribute knowledge to
the HIV testing practice by highlighting provider-related barriers to HIV testing and
possible steps that might improve provider-initiated HIV testing in the acute care setting.
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In addition, the knowledge gained from this study could give policymakers and hospital
administrators critical information to help them deploy resources to combat HIV
infection. Increasing HIV testing in health care settings especially the ED has many
benefits, including the mitigation of HIV infections from people who lack their
seropositive knowledge, delaying the progression of HIV infection into AIDS, timely
access to HAART, and early counseling.
Summary
Since the first cases of HIV/AIDS were reported in 1981, about 658,500 people
have died in the United States and approximately 13,700 people died in 2012 from AIDSrelated complications (CDC, 2015c). The number of existing cases of HIV infection in
the United States exceeds 1.2 million, and its prevalence is 0.39% among U.S.
individuals 18-59 years old (CDC, 2015c; Woodring et al., 2015). Although the rate of
new HIV infections declined over the years, the incidence of HIV infection has plateaued
at around 50,000 cases annually in the United States. Challenges remain when it comes to
the prevention and control of the HIV/AIDS epidemic.
In conjunction with advanced treatment regimens for HIV infection, early HIV
testing is credited with the reduction in HIV transmissions and the progression to AIDS
(NIH, 2015b). These more advanced treatment regimens have enabled HIV-infected
people to live longer. However, many Americans who are possibly infected with HIV
lack knowledge of their serostatus, and only one third of U.S. HIV/AIDS patients have
achieved the recommended viral load suppression (NIH, 2015b). Lack of access to HIV
testing services and timely diagnosis has denied many HIV/AIDS patients the benefits
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associated with existing therapeutic regimens. Furthermore, because many have not been
diagnosed, they provide possible channels for continued transmission of HIV.
Routine HIV testing is an important measure in preventing HIV/AIDS, especially
point-of-care rapid HIV testing that enables results to be made available in a short period.
Routine HIV testing leads to early diagnosis, which enables individuals to minimize risky
sexual behaviors and seek life-prolonging therapies. The ED environment is a unique
place where HIV testing can have a significant impact in reducing the number of people
who are unaware of being infected with HIV. Most acute care and ED providers do not
offer routine HIV testing as recommended by the CDC (Branson et al., 2006), United
States Preventive Services Task Force (USPSTF, 2015), and the American College of
Emergency Physicians (ACEP, 2014). Research shows that there are missed opportunities
for capturing large groups of people who have never been tested for HIV during visits to
acute care centers (Dorell et al., 2011; Klein, Martin, Quinlivan, Gay, & Leone, 2014).
Many individuals who were diagnosed with HIV infection on their initial test, as well as
late testers, were more likely to have had several ED visits prior to getting tested (Nakao
et al., 2014). It is important to determine the extent to which provider type (NP, PA,
MD), characteristics (age, gender, race/ethnicity, years of experience), and practice (ED,
general medicine, internal medicine, OB/GYN, infectious disease, and pediatrics) impact
HIV testing in the acute care setting.
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Chapter 2: Literature Review
The purpose of this quantitative cross-sectional study was to examine the
relationships between HIV testing and provider-related characteristics in the acute care
setting. The HIV epidemic has attracted considerable attention from many stakeholders
for various reasons, and chief among these are controlling the transmission of HIV/AIDS
and mitigating HIV-related healthcare disparities. Researchers have devoted significant
resources to studying the many facets of HIV transmission. However, literature
addressing the impact of provider characteristics and provider type on HIV testing in the
acute care setting is lacking. The benefits of reducing the number of persons with
unknown HIV serostatus are well known (Connor et al., 1994; Hall, Holtgrave, &
Maulsby, 2012; Hays et al., 1997; Marks, Crepaz, Senterfitt, & Janssen, 2005), but the
utilization of HIV screening to determine HIV serostatus is low (Klein et al., 2014;
Nakao et al., 2014; Tai & Merchant 2014) despite HIV testing being a free service in the
United States and being covered by many health insurance providers.
This literature review focused on the prevailing trends in HIV testing as well as
provider-related barriers to HIV testing in acute care settings in the United States and to a
lesser extent in Chicago, Illinois. Furthermore, I explored HIV testing barriers and the
influence of personal, behavioral, and environmental factors. Emphasis was placed on
literature addressing the role and impact of acute care providers with respect to HIV
testing. Additionally, I explored the impact of early HIV diagnosis, late HIV diagnosis,
and lack of awareness of seropositive status on HIV transmission. In this chapter, I
discuss the literature search strategies; HIV testing trends; lack of awareness; barriers;
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providers’ approach, attitude, and behaviors toward HIV testing as well as the theoretical
framework.
Literature Search
I used the following databases: CINAHL, simultaneous MEDLINE/CINAHL, and
PubMed. I also used Google Scholar, Google.com, and the Liebert Publishers website.
The CINAHL, PubMed, and MEDLINE databases were accessed through Walden
University’s library. Google Scholar, Google.com, and Liebert Publishers were accessed
through the World Wide Web. Several search terms were used either alone or in
combination: HIV infection, emergency department, HIV screening, HIV testing,
behaviors, self-efficacy, modeling, learning, provider type and HIV testing, providers’
attitudes and HIV testing, social cognitive theory, HIV/AIDS, provider characteristics,
and African Americans. The initial query in CINAHL/Medline yielded 4,700 articles that
were narrowed to 133 articles and then 85 articles based on relevance to the research
problem. In PubMed, 258 articles were located. Abstracts from articles were examined,
and only articles that addressed HIV testing and associated behaviors among acute care
providers were selected for thorough review. Articles were eliminated if they were older
than 5 years, published in a language other than English, addressed countries other than
the United States, based primarily in other settings (not acute care or ED), or did not
address most of the variables in my study.
Theoretical Framework
The theoretical foundation for this study was based on SCT. The origin of SCT
can be traced to the work of Miller and Dollard (1941), who proposed social learning
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theory in response to behaviorists’ theories common during that era. However, social
learning theory lacked qualities to explain complex processes involved in behavior
acquisitions and retention, prompting theorists to modify the social learning theory.
Bandura and Walters (1963) expanded social learning theory by adding vicarious
reinforcement and observation learning as other essential concepts embedded in the
complex human behavioral and learning landscape. Realizing that social learning theory
was not adequate in mediating emerging learning and behavioral patterns, Bandura
(1977) further expounded on social learning theory by incorporating the element of selfefficacy. Bandura (1986) refuted the behaviorists’ psychoanalytic and drive reduction
approaches by recognizing the dynamism of cognitive and information-processing
capacities related to human functioning and learning, and renamed it SCT. This new
theory proposed a view of human functioning that emphasized cognitive functioning,
self-regulation, evaluation, and purposive adaptations as driving forces of learning and
behavior, rather than mere reactions to external and internal stimuli (Bandura, 1986).
Social Cognitive Theory
SCT provides a strong foundation for examining how humans construct reality,
adapt, change, and function within the larger social network. This theory incorporates
other disciplines such as sociology and political science to reflect the depth of cognitive
capacity in human functioning and the totality of lived experience. SCT posits that
knowledge and behavior acquisition are largely a function of observations and modeling
that occur within the social context, and this process has certain mediating elements such
as motivation, self-influence, and perceptions (Bandura, 1993). SCT is known for its
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central proposition of triadic reciprocality, in which human behavior is thought to
emanate from the relationship between personal, behavioral, and environmental forces
(Bandura, 1986). Reciprocal determinism is another SCT concept pegged on the idea that
dynamic interactions among behavioral, personal, and environmental factors are
responsible for acquisition of behavior, knowledge, learning, adaptation, and change in
the universe of human functioning (Bandura, 1986). What differentiates SCT from its
predecessors is its emphasis on mutual interdependence, the capacity for humans to
change their environment and vice versa. Although the environment in which a person
exists has great influence on the person’s behavior and experiences, the person also can
change the environment directly or indirectly to attain specific outcomes. Some of the
SCT concepts are self-efficacy, reciprocal determinism, observational learning, outcome
expectation, self-regulation, collective efficacy, and incentive motivation (Bandura,
2004). I examined how SCT and its constructs have been applied in previous HIV-related
studies, and how such application might inform the current study.
Self-efficacy. Perceived self-efficacy is the belief that people are not only able to
overcome existing challenges, but are also able to become successful using resources at
their disposal (Bandura & Wood, 1989). Self-efficacy is a combination of several factors
that affect the capacity of people to achieve their objectives through learning and
adopting appropriate behaviors. The extent to which individuals can perform despite
obstacles to reach certain outcomes depends on their perceived self-efficacy. Selfefficacy is a complex phenomenon by which individuals mobilize their talents, skills, and
social capital to enable them to move from one point to another (Bandura, 1986). Self-
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efficacy influences the degree of outcomes that people expect, and positive self-efficacy
is more important than skills alone in determining peoples’ performance and resilience
(Bandura, 1986, 2004). To highlight the effect of self-efficacy in relation to adherence to
HIV treatment regimen, Nokes et al. (2012) indicated that adherence to HAART was
more significantly related to perceived self-efficacy than other environmental or social
support factors. Additionally, Schnall et al. (2013) noted that among ED providers in two
New York City hospitals, those with higher self-efficacy were more likely to offer HIV
testing to their patients. McGarrity and Huebner (2014) observed that cognitive
determinants alone may not fully account for the likelihood that men of low
socioeconomic status (SES) will be offered HIV testing in acute care settings. Beyond
influencing how providers conduct HIV testing in acute care settings, self-efficacy might
also impact patients’ willingness to be tested, which might impact HIV testing
completion rates.
Reciprocal determinism. This concept of SCT underscores the idea that personal
behaviors are influenced by personal and social environmental forces, and personal
behaviors influence the personal and social environment. People’s choices, expectations,
behaviors, and level of self-efficacy determine the degree of control that they have over
the environment in which they operate (Bandura, 1986; Bandura & Wood, 1989). Schnall
et al. (2013) noted that the type and cost of the available HIV test, the number of staff,
the general infrastructure, and the management style influenced the success of HIV
testing in an ED environment. Providers with better HIV testing knowledge, self-efficacy,
and intention to test were more likely to offer HIV testing to patients (Schnall et al.,
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2013). Although existing barriers in the acute care environment influence the capacity of
providers to conduct HIV testing, providers have certain capabilities that if fully
employed could improve the HIV testing rate.
Observational learning. People acquire new knowledge and behavior partly
through modeling. The presence of various types of models enables people to obtain,
evaluate, utilize, and retain relevant and useful characteristics that cultivate new behavior
(Bandura, 1986). The process of observational learning is not merely a mimicking
exercise, but rather an intricate undertaking in which meaningful feedback and selfevaluation determine what people choose to adopt and what they choose to discard
(Bandura & Wood, 1989). In a systematic review of the effectiveness of video-based
interventions on behavior change, Toung, Larsen, and Armstrong (2014) noted that
participants adopted healthier practices, such as self-breast exams, HIV testing, female
condom use, prostate screening, and increased sunscreen use, following a video-based
educational intervention. It may be possible to increase HIV testing in acute care settings
by adopting modeling as a means of stimulating behavior change among providers and
ancillary staff.
Outcome expectations. Behavior choice, performance, goal setting, attitudes, and
the degree of effort deployed rely on the type and magnitude of outcome expected.
Furthermore, behavior is influenced by the social norms, outcome consequences, and
value placed on those expected outcomes (Bandura, 1986; Bandura, 2004). People are
likely to alter their actions and consider different alternatives if they are assured of
desirable outcomes. Musheke, Bond, and Merten (2013) found that discordant HIV

30
testing results among couples were associated with severe consequences such as spouse
abandonment, economic hardship, abuse, and power struggle, and that willingness for
couples to undergo voluntary HIV testing was difficult. Additionally, some people
delayed seeking HIV testing and treatment for a significant amount of time because of
intense fear associated with discomfort, stigma, rejection, and other social ills associated
with others knowing they are HIV positive (Westmaas et al., 2012). To decrease the
number of people who are unaware of their HIV status, strategies to mitigate unpleasant
consequences associated with being known to be HIV positive must be utilized so that
HIV testing can be promoted. Desirable outcomes, such as reimbursement for ED-based
HIV testing services, might encourage providers to increase HIV testing.
Self-regulation. People have the capacity to use judgment regarding when and
what types of actions to take, what behaviors and attitudes to avoid, and what outcomes
to pursue to have greater degree of control over their life. People who master selfregulation are better placed to reach their potential by adopting desirable behaviors and
aligning their goals with their personal values as well as social norms (Bandura, 1986;
Bandura & Wood, 1989). To the extent that people choose to self-regulate, they also
engage in ongoing self-evaluations as well as constant assessment of environmental
challenges they must overcome as part of the goal-directed enterprise. In their
investigation of voluntary counseling and testing attitudes among Black MSM, St.
Lawrence et al. (2015) found that most Black MSM did not wish to know their
seropositive status, and most had tendencies to avoid health care providers, thereby
delaying chances of getting tested for HIV, which resulted in lost opportunities for timely
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viral suppression. Enhanced self-regulation and heightened urgency to evaluate the
consequences of one’s actions might lead to a change in behavior, adoption of better
skills, and inclination toward seeking adequate knowledge. Knowledge and skills among
providers without self-regulation and other cognitive variables might impede uptake of
HIV testing in the acute care setting.
Collective efficacy. People seldom make significant changes in the social order
by acting alone. Self-efficacy affords people with the enormous potential to work toward
their goals. However, broader societal obstacles require collective actions to overcome.
Perceived collective efficacy (Bandura, 1986) is the shared belief among people in their
collective capacity to work together by combining resources, skills, and efforts for the
greater good of the community to which they belong. To change the current state of
affairs and overcome existing challenges within group settings, involved parties who use
socially focused agendas are more likely to succeed. The cognitive value of collective
efficacy was demonstrated by Quinlivan et al. (2013), who noted that women of color
who were at increased risk of HIV infection had better outcomes related to HIV testing,
entry into care, and retention in care when they had strong support from family, friends,
and health care personnel. Within the acute care environment, the success of HIV testing
could be enhanced by various programs and the engagement of all stakeholders including
providers, administrators, managers, patients, and all other ancillary staff who have direct
contact with patients.
Incentive/motivation. SCT posits that to enhance chances of reaching goals,
people are likely to alter undesirable behaviors in favor of behaviors and attitudes that
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promote successful outcomes. People are motivated by both intrinsic and extrinsic
incentives such that when positive outlooks prevail and valued outcomes ensue,
antecedent behaviors are reinforced (Bandura, 1986). The utility of reward and
punishment is linked to the capacity to encourage or discourage certain behaviors or
activities. St. Lawrence et al. (2015) noted that financial incentives resulted in greater
likelihood of HIV testing among hard to reach MSM. Similarly, Westmaas et al. (2012)
found that their study participants were more likely to undergo HIV testing if they
received support and motivation from family, friends, and their community at large.
Furthermore, it is widely believed that adopting financial reimbursement for HIV testing
services might encourage increased offering of HIV testing among acute care providers.
Similarly, point-of-care rapid HIV testing is often cited as a source of added ED costs,
which has prompted alternative testing methods some of which delay results and in the
end, preclude linkage to care and lead to late testing.
Rationale for SCT
A theoretical foundation is central to any research endeavor in many ways, and it
is certainly more integral when applied toward understanding health-related behaviors.
No single theory is superior to others in all scenarios; therefore, researchers should utilize
theories to the extent they think theory makes sense with the specific research problem
and question (Glanz, Rimer, & Viswanath, 2008). In the current study, I chose to apply
SCT because of its premise that human behavior, and how behavior is acquired,
implemented, and sustained within individual and group frameworks, is best understood
by examining how it is shaped by the dynamic interplay of behavioral, personal, and
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environmental forces. The SCT is appropriate and suitable for the current study given the
complex nature of the acute care environment and many variables that influence how
providers perform in any given scenario. Integration of the SCT alongside other
interventions and programs intended to improve HIV testing could inform existing acute
care practice related to HIV testing. Therefore, a problem such as low HIV testing in the
acute care settings might appear simple on the surface, but underneath it is different
levels of barriers that are cumbersome to delineate. Additionally, several aspects within
the SCT provide ample dimensions under which personal factors (knowledge,
expectations, attitudes), behavioral factors (skills, self-efficacy, practice), and
environmental factors (social norms, access/control, physical/social environment) can be
evaluated, especially the influence they exert on the type of behaviors providers choose to
adopt. Moreover, some of the theories commonly applied in health behavior studies, such
as health belief model (HBM) and the theory of planned behavior (TPB) share many
elements. Nonetheless, the SCT is strongly suited for the current study, because it
encompasses broader elements of behavior and emphasizes reciprocal determinism.
How SCT Relates to the Present Study
Like many other studies in the social sciences landscape, especially studies that
address HIV/AIDS, the present study is focused on the role of personal behaviors and
how those behaviors impact certain health-related interventions. HIV testing is a very
important aspect of healthcare, and when it is utilized well, it can provide patients with
opportunities to get diagnosed early and thus obtain HIV treatments in a timely fashion.
More importantly, a robust HIV testing program promotes the public health agenda of
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reducing HIV infections. However, when there is a clear problem of low HIV testing as it
is in acute care settings, the use of theory becomes critical in effort to deconstruct how
provider-related behaviors undermine overall HIV testing. The SCT informs the present
study in many ways by providing the lens through which the dynamic phenomenon of
HIV testing in acute care and ED settings can be examined. While the present study did
not examine all aspects of HIV testing in the acute care environment, it focused on the
impact of provider type and characteristics on HIV testing in the acute setting including
ED. This approach, combined with the variables of interest, is well aligned with the
SCT’s personal and behavioral determinants of learning and behavior acquisition. The
three main constructs in the SCT (personal, behavioral, and environmental) provided the
present study with a framework to allow examination of how the interrelatedness of
provider characteristics impact routine HIV testing in the acute care setting. Per Glanz et
al. (2008), studies that are grounded in strong theoretical frameworks lend themselves to
be easily generalized to other populations, and provide researchers with better methods to
compare the effectiveness of behavior-based interventions across many research findings.
The findings from the present study could inform acute care practice in areas related to
HIV testing. Therefore, incorporating the SCT strengthened the foundations of this study
and its findings, which could make it more generalizable towards other acute care settings
where routine HIV testing is lacking. Furthermore, when practitioners adopt measures
that are based on strong theoretical foundations to inform practice, it becomes markedly
easy to change underperforming environments and to promote desired behavior (Glanz et
al., 2008). The research questions in the present study were informed by the SCT. This
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study might also in the process of addressing these questions contribute toward HIV
testing and perhaps strengthen the SCT. The first question was aimed at examining how
provider type and characteristics relate to HIV testing in the acute care environment. To
investigate this phenomenon in detail and delineate correlates of HIV testing in the acute
care setting, it was appropriate to utilize the SCT because it could illuminate the
relationships among variables in the research question. As demonstrated by several other
studies discussed early, the SCT has been widely used by many researchers who among
other areas focused on HIV testing, prevention, control, risk behavior reduction, and
treatment adherence. Therefore, in my assessment, and in tandem with the previous
research, I believe that the SCT is appropriate and suitable for the present study.
HIV Testing
There were over 1 million U.S. residents who were living with HIV infection at
the close of 2011, and a sizable number (160,000) lacked knowledge of being infected
with HIV (CDC, 2013). Additionally, the annual rate of new HIV infections has remained
steady at about 50,000 new infections since the 1990s (CDC, 2012; Hall et al., 2008).
Despite HIV/AIDS being an epidemic with serious implications, only 37.5% of U.S.
adults over 18 years underwent HIV testing in 2014 (CDC, 2014a). In Chicago, Illinois,
the rate of HIV infections is 2.5 times greater than the national average, and HIV
prevalence is approximately three times more than the national average (Chicago
Department of Public Health [CDPH], 2014). The CDPH (2014) reported that although a
decrease was noted among certain age groups, there was an increase of about 5%
annually in HIV incidence among MSM. Protracted HIV infections and subsequent

36
progression to AIDS coupled with disease burden have provided impetus for a series of
recent federal and state policy changes to mitigate the HIV epidemic in the United States.
The CDC in 2006 made sweeping changes in its HIV testing policy by recommending
routine HIV testing in all healthcare settings including EDs, especially in areas where
undiagnosed HIV prevalence exceeds 0.1% (Branson et al., 2006). This change in HIV
testing policy directed that all patients ages 13 to 64 seeking medical care should be
offered HIV testing in a nontargeted manner unless they declined (Branson et al., 2006).
Moreover, the CDC recommends annual HIV testing for individuals who are at increased
risk of contracting HIV infection, such as injection drug users (IDUs), MSM, prostitutes,
partners of HIV-infected individuals, and heterosexual partners who are not faithful to
their partners. Echoing CDC recommendations, the USPSTF revised its 2005 HIV testing
guidelines by publishing new recommendations instructing providers to offer routine HIV
testing to adolescents and adults between 15 and 65 years of age (Moyer, 2013). Faced
with an unrelenting HIV infection epidemic, most U.S. states followed suit by adopting
new HIV testing regulations based on the CDC and USPSTF guidelines. For example, the
Illinois Department of Healthcare and Family Services (IDHFS, 2012) revised its HIV
testing regulation by eliminating the need for a separate written consent and precounseling before HIV testing, and adopted the opt-out screening approach to promote
routine HIV testing in healthcare settings. These measures aimed at addressing growing
concerns regarding the spread of HIV are some of the most recent changes. However,
there is a long history of prior HIV testing policies, many which had to be repealed to
facilitate better and more focused HIV testing strategies.
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Routine HIV Testing
The elimination of HIV transmission is dependent on timely and proactive HIV
testing, treatment with HAART, retention in care, and counselling. Despite marked effort
and regulations that have been directed at routinizing HIV testing, implementation of
universal HIV testing has not been routine. After investigating how healthcare facilities
responded over the years to the new CDC testing recommendations, Tai and Merchant
(2014) noted that many healthcare facilities failed to make meaningful changes to their
HIV testing procedures or made very modest changes. In a multi-hospital, multi-state
survey regarding HIV testing practices, only 5.8% of the 638 hospitals located in regions
with known HIV prevalence screened all patients for HIV, and only 26.2% screened
some patients for HIV (Herrin et al., 2013). Additionally, (Herrin et al., 2013) indicated
that only 6.6% of the 376 hospitals that were in areas with HIV prevalence of ≥ 0.1%
confirmed screening all patients for HIV, while only 7.5% of the153 hospitals in areas
with HIV prevalence ≥ 0.3% confirmed screening all patients for HIV. Even in states like
New York (NY) which passed laws that mandated providers to offer HIV testing for
which clinicians underwent formal training, routine HIV testing still failed to take hold as
initially anticipated (Anaya et al., 2012; Arbelaez et al., 2012; Egan et al., 2014). The
failure to implement routine HIV testing in healthcare settings has precluded many
patients from receiving essential and critical health benefits related to HIV care. In
addition, many patients who presented in ED were not made aware that HIV testing was
available and that it could be done swiftly with results available before discharge
(Aronson et al., 2014). Failure on the providers’ part to execute routine HIV screening as
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recommended by the CDC and several other agencies represents a real challenge to the
prevention of HIV transmission. Moreover, the fact that most providers having
significant contact with patients during normal care visits did not offer routine HIV
testing represents missed opportunities for early diagnosis and timely interventions
(Dorell et al., 2011; Klein, Martin, Quinlivan, Gay, & Leone 2014). Perhaps the most
intriguing observation in the HIV testing landscape was made by authors who observed
that most primary and acute care patients generally agreed with the opt-out HIV testing
approach when it was offered despite widespread providers’ indifferences to the same
approach (Futterman, Michaels, Stafford, Carlson, & Wolfson, 2002; Kinsler et al.,
2013). Considering there is a significant number of persons who are unaware of their
HIV serostatus and the risk they pose to others, it is very important to examine factors
that could increase HIV testing.
Unawareness of HIV Infection
The large number of persons who do not know they have HIV/AIDS despite
efforts to provide free HIV testing in various venues both public and private is
worrisome, and remains a concern for the policy makers and public health practitioners.
Of the millions infected with HIV worldwide, about 33% are unaware that they are
infected (WHO, 2012). Given that people can move quickly and freely anywhere in the
world, implementation of universal routine HIV screening in multiple settings is
essential. HIV infection unawareness is even greater among MSM and especially young
minority males, groups that are disproportionately affected by the HIV/AIDS epidemic
(CDC, 2010; Copeland et al., 2012). Felsen et al. (2015) noted that as many as 75% of
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patients who visited ED in 2011 had not previously been tested for HIV, and Clauss et al.
(2011) found that about 29% of HIV-infected patients in ED were not aware that they
were HIV positive. Having HIV infection and not knowing is not only harmful to the
carriers, but also to those who encounter them, especially those sharing IDUs and
heterosexual partners. It is believed that persons who are infected with HIV and who
remain unaware will continue to spread the virus to others due to risky sexual behaviors
and other subtle routes of transmitting the virus (Chen et al., 2012; Mark, Crepaz,
Senterfitt, & Janssen, 2005). The actual number of HIV infections associated with people
who lack their seropositive status is difficult to estimate. However, Marks et al. (2005)
noted that about 50%-70% of new HIV infections were due to persons not aware of being
infected with HIV. Researchers have noted reduction in risky sexual behaviors, such as
multiple sexual contacts, and an increase in utilization of protective measures such as
condom use in patients following an HIV diagnosis (Fox et al., 2009; Steward et al.,
2009). Generally, HIV testing was highly acceptable when offered, and when people
learned of being infected with HIV, they were more likely to alter risky behaviors which
reduced the potential for HIV transmission (Marks et al., 2005; Sankoff et al., 2012; Setse
& Maxwell, 2014). Ultimately, an improvement in promoting routine HIV testing could
slow down the incidence of HIV infections and the progression to AIDS. Significant
number of persons in the United States get diagnosed with AIDS within 12 months of
HIV diagnosis (late testers); this worsens their survival chances, diminishes quality of
life, and precludes benefits associated with HAART (CDC, 2013; Tang, Levy, &
Hernandez, 2011). Considering the HIV incidence, the lack of routine testing, and the
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burden associated with late testing, it is appropriate to examine barriers that hinder
routine HIV testing and earlier diagnosis in the acute care environment.
Barriers to HIV Testing
The lack of routine HIV testing in EDs and other healthcare settings as
recommended by the federal and state agencies represents a major hurdle in preventing
HIV transmission. Acute care providers function under complex network where several
factors might be beyond their control, therefore limiting their capacity to conduct
universal and routine HIV testing. Nevertheless, providers have autonomy to order any
tests, including HIV testing. One barrier to universal HIV testing in the acute care
settings according to previous studies is the targeted HIV testing; where health care
providers conduct, risk based screening and testing (Czarnogorski et al., 2011; Nakao et
al., 2014; Pringle, Merchant, & Clerk, 2013). The CDC recommends non-targeted HIV
testing in health care settings where all patients ages13 to64 years should be offered HIV
testing unless they opt-out (Branson et al., 2006). This recommendation is aimed at
providers who practice in areas with known HIV prevalence of ≥ 0.1%. Many researchers
have suggested a wide implementation of non-targeted HIV testing in healthcare settings
as a strategy to increase HIV testing rates, because it is widely accepted by patients
(Coeller, Kuo, & Brown, 2011; Copeland et al., 2012; Kinsler et al., 2013; Sankoff et al.,
2012). Furthermore, Copeland et al. (2012) indicated that when a non-targeted HIV
testing approach was utilized among MSM, 16% of the newly diagnosed were unaware of
being infected, and 30% of those who tested positive reported being given a negative
diagnosis in the previous year. Those opposed to routine HIV testing in ED
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environments have cited time constraints; indicating that focusing on HIV testing and
referral takes away crucial time from patients who have emergency needs. Contrary,
Coeller et al. (2011) indicated that even when implemented within a busy ED
environment, non-targeted HIV testing did not add to the length of time spent per patient.
Despite multiple researchers who have demonstrated the effectiveness of non-targeted
HIV testing in healthcare settings as recommended by the CDC, other researchers found
targeted HIV testing approach to be equally effective, and devoid of the increased costs
and logistic impediments associated with the non-targeted testing (Christopoulos et al.,
2011; Holtgrave, 2007; Lubelcheck et al., 2011; Schrantz et al., 2011). Additionally,
Christopoulos et al. (2011), Lubelcheck et al. (2011), and Schrantz et al. (2011) observed
that the targeted HIV testing approach was effective at increasing HIV testing and
diagnosis without requiring additional resources. However, Prekker et al. (2015) and
White et al. (2013) found that in the acute care setting the differences resulting from
targeted and non-targeted HIV testing were marginal with regards to testing rates;
although non-targeted testing led to identification of persons who had been previously
diagnosed with HIV infection and those who were late testers. In agreement with Prekker
et al. (2015) and White et al. (2003), Houkoos et al. (2011) noted after conducting a
meta-analysis that current literature yielded limited evidence to support either strategy as
being better. The non-targeted HIV testing approach is recommended by the CDC
because it provides broader access to HIV testing unlike the targeted HIV testing
approach which is difficulty to implement because it is based on patients’ HIV risk
profile and providers’ perceptions of patients’ behavior profile. The challenge facing ED
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and other acute care providers who rely on targeted HIV testing is when patients have
low perception of HIV risk profile but whose actual risk is high, which leads to decreased
testing (Pringle, Merchant, & Clerk, 2013). Thus, the shortfalls associated with targeted
HIV testing have been highlighted by researchers who observed that large numbers of
persons newly diagnosed with HIV infection and many late testers had multiple health
care visits (3-5) prior to receiving initial HIV test (Liddicoat et al., 2004; Nakao et al.,
2014). It is likely that the targeted HIV testing approach could lead to missed
opportunities for timely HIV testing. Although the non-targeted approach might be
costly, it leads to more HIV diagnoses and better overall outcomes in the HIV care
continuum (Houkoos et al., 2013). Given the high HIV prevalence and incidence in
certain geographic areas and population groups, the initial cost of implementing the nontargeted HIV testing program could be offset by the gains associated with early therapy
initiation, and therefore less resources spent on opportunistic illnesses and debility
associated with full blown AIDS. Considering researchers found that undiagnosed HIV
infection rate among patients who declined to be tested during routine care in emergency
department was significantly higher [RR= 2.74] (Czarnogorski et al., 2011), the nontargeted HIV testing approach seems to be the better alternative.
Previous researchers have revealed several healthcare-related barriers that
preclude the implementation of routine HIV testing in the acute care settings. Some of the
barriers are commonly cited by many ED-based providers as reasons for lower testing
rates. Some barriers are related to resource constraints such as: inadequate staffing and
test kits (Egan et al., 2014; Houkoos et al., 2013), and others are due to time constraints
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(Korthuis et al., 2011; Kinsler et al., 2013). Furthermore, providers’ age, gender, and
ethnicity have been cited as possible barriers to HIV testing in the ED environment (Setse
& Maxwell, 2014). Additionally, provider-specific barriers such as: lack of knowledge
regarding HIV testing guidelines, discomfort discussing sexual matters with patients, and
attitudes and beliefs toward HIV testing were also identified (Hunter et al., 2012; Kinsler
et al., 2013; Korthuis et al., 2011; Lanier et al., 2014; Levison et al., 2012). Patientsspecific barriers to HIV testing that were identified included: lack of medical insurance,
stigma, test refusal, lack of HIV-related education, poor knowledge of medical rights and
services, cost perception, perception of health care centers, and mistrust toward providers
(Beattie et al., 2012; Deblonde et al., 2010; Flowers, Knussen, Li, & McDaid, 2013; Holt
et al., 2011; Huang et al., 2012; Li et al., 2012; Mills et al., 2011; Mimiaga et al., 2009;
Prestage, Brown, & Keen, 2012; Sankoff et al., 2012,Schwarcz et al., 2011). To
successfully design, implement, and evaluate programs aimed at routinizing HIV testing,
it is important to eliminate testing-related barriers. Elimination of barriers to HIV testing
might require multi-pronged approaches. I examined the lack of routine HIV testing in
the acute care setting related to provider-specific characteristics.
Characteristics of ED Patients
Responding to the changing HIV testing landscape and the continuous spread of
HIV infections, the ACEP revised its HIV testing guidelines in 2014 in a policy statement
and recommended routine and timely HIV testing in EDs, like other medical conditions
(ACEP, 2014). Although there are several locations to obtain an HIV test such as: local
health departments, doctors’ offices, and many community venues, the ED is the venue of

44
choice for a large population segment, therefore representing a unique testing venue. EDs
are already utilized by many people for non-emergency visits and other primary carerelated needs. In a systematic literature review conducted by Uscher-Pines, Kellermann,
and Mehrotra (2013), approximately 39% of all ED visits were for non-emergency
reasons. Researchers noted that often EDs are over-utilized and overwhelmed by many
patients who are uninsured, underinsured, or poor, and those who use ED services as the
only source of medical care, or for non-urgent primary care issues (Cunnigham, 2011;
Kaiser Family Foundation, 2009; Nakao et al., 2014; Sankoff et al., 2012). Most of the
population subgroups who are disproportionately affected by HIV/AIDS constitute MSM,
Blacks, and Hispanics who tend to over-utilize ED services (CDC, 2012; CDC, 2015g;
Nunn et al., 2011). These groups are often marginalized, carry greater burdens of poverty,
and are likely to engage in risky sexual and drug-related behaviors (CDC, 2012; CDC,
2015g; Nunn et al., 2011). When opportunities arise due to groups disproportionately
affected by HIV/AIDS presenting at ED settings, routine non-targeted HIV testing should
be offered. Coeller et al. (2011), Nakao et al. (2014), Rothman et al. (2012), Sankoff et al.
(2012), and Setse and Maxwell (2014) observed that among patients who visited EDs:
those who had state sponsored insurance or Medicaid, were self-pay, and were Black or
Hispanic were more willing to undergo HIV testing when offered. Among ED patients
who were likely to accept HIV test, many engaged in HIV-risk behaviors such as: having
sexual activity with known HIV-infected persons, exchanging sex for drugs or money,
sharing of injecting drug needles, and engaging in unprotected sexual acts with multiple
persons (Pringle et al., 2013). Because HIV exposure is associated with risky behaviors,
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many ED patients underestimate their HIV risk profile, and thus failed to provide
clinicians with information that could lead to HIV testing, resulting in higher ED
seroprevalence (Clause et al., 2011; Nunn et al., 2011; Pringle et al., 2013; Setse &
Maxwell, 2014). It can be argued that offering routine HIV screening and testing in EDs
is of great value without which many ED patients with hidden risks for HIV infection
could miss being timely diagnosed. Pisculli et al. (2011) and Setse and Maxwell (2014)
indicated that 24%-29% of patients declined to be tested for HIV of which many were
women and those over 50. Research shows that HIV infection is prevalent among persons
over the age of 55 who represent 24% of the HIV prevalence in the U.S, and in women
who represent 23% of the HIV prevalence whereby many women contract HIV infection
from heterosexual relationships (CDC, 2015e; CDC, 2015f). EDs being touted as
opportune venues where non-targeted HIV testing should be widely implemented, more
effort should focus on those who refuse to be tested (opt-out), especially women, people
over 55 years, and minority groups. Czarnogorski et al. (2011) compared patients who
accepted and those who declined HIV testing in ED noting that patients who opted-out
had a preponderance of undiagnosed HIV infections. Perhaps the most significant finding
associated with the lack of HIV testing in ED setting as noted by Copeland et al. (2012)
and Nakao et al. (2014) was that among patients who got tested, many received AIDS
diagnoses within 12 months of HIV diagnoses and others presented with CD4 counts less
than 200 cells/mm³. Not only do many persons receive initial HIV diagnosis in EDs,
many also present with low CD4 count; but, several had previous ED visits up to 3
encounters on average before they were finally tested (Nakao et al., 2014). Considering
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researchers observed that 82% of ED patients who were diagnosed with HIV indicated
they would not have tested had the test not been offered (Setse & Maxwell, 2014), ED
services should be maximized to include routine HIV testing. Knowing the ED
population demographics and testing patterns linked to minority groups, women, MSM,
and those over 50 years, routine HIV testing should be promoted and widely
implemented in ED settings. The existing ED infrastructure is adequate to allow for costeffective routine HIV testing consistent with CDC guidelines (Torres et al., 2011).
Provider Approaches to HIV Testing
Providers in acute care settings have greater autonomy with regards to the
implementation of HIV testing. In the ED environment, providers perform several healthrelated screenings and testing both for acute and chronic conditions among patients.
However, many ED providers consider the addition of HIV testing to other ED services a
significant burden that takes time away from those in need, thus negatively impacting
patient outcomes. Due to the lack of

HIV testing in many acute care settings, it is

possible provider-related characteristics and provider type are factors that preclude HIV
testing. In a study that examined nurses’ and providers’ impact on HIV testing, Bender
Ignacio et al. (2014) indicated that among patients who did not complete the HIV test,
8.4% did so because providers failed to offer the test, and of the 36% who opted to be
tested at triage, only 23.5% got tested. When ED providers offered routine non-targeted
HIV testing, patients readily accepted and completed the test before being discharged
(Bender Ignacio et al., 2014; Kinsler et al., 2013). In another study, Meanley et al. (2015)
observed that the likelihood of patients agreeing to undergo HIV testing was higher when
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engaged by providers in discussions about sexual health. Although several factors such
as: lack of HIV testing programs, inadequate staffing, insufficient testing kits, patientrelated factors, and failure to implement routine HIV testing have emerged as
considerable barriers to HIV testing in the acute care settings (Egan et al., 2014;
Houkoos et al., 2013), it is also evident that acute care providers have an impact on HIV
testing (Bender Ignacio et al., 2014; Hunter et al., 2012; Kinsler et al., 2013; Korthuis et
al., 2011; Lanier et al., 2014; Levison et al., 2012 ).
Provider Attitudes and HIV Testing
Cabana et al. (1999) indicated that common provider attitudes that impact HIV
testing stem from opposition to established testing guidelines, and are associated with
low self-efficacy, negative outcome expectancy, and the influence of barriers that
providers face in their practices. For example, despite many patients having supported the
2006 CDC testing recommendations, clinicians indicated that the same recommendations
were not ethical (Merchant et al., 2012). In a survey of providers who practiced in an
urban medical center emergency medicine, internal medicine, pediatrics, and
obstetrics/gynecology, few followed the recommended HIV testing guidelines (Bares et
al., 2014). Moreover, Akhter et al. (2012) observed that providers with higher selfefficacy perceptions were likely to offer HIV test. Akhter et al. (2012) only focused on
providers’ attitudes and behaviors related to utility of rapid HIV testing in pediatric ED,
thus a survey of the entire system utilizing other testing methods could result in
discordant findings. Furthermore, in a dental school-based study, 88.2% of patients
readily accepted rapid HIV testing when approached by faculty or students; but, 27.4% of
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faculty providers were neutral and 26.4% were partially agreeable with the
implementation of rapid oral HIV testing (Nassry et al., 2012). Researchers in an
Australian survey conducted among providers from public-based HIV clinics found
most providers believed that point-of-care rapid HIV testing interfered with routine clinic
operations (Conway et al., 2015). Providers’ attitudes toward HIV testing were further
examined in a qualitative study conducted among primary care and infectious disease
specialists from the Mississippi Delta. In the study, Sison et al. (2013) observed that
providers failed to perform routine HIV testing due to beliefs it belonged in the public
health departments, and due to believes they might be perceived negatively by patients.
ED providers were surveyed in a New York study after a new law mandating HIV testing
in all patients ages 13 to 64 years was established; researchers indicated that only 65% of
providers offered HIV testing per the mandate (Egan et al., 2014). Six months after the
establishment of an HIV testing program in another ED, only 38% of providers continued
to support the program (Arbelaez et al., 2012). Additionally, in a study among ED
residents who had HIV testing training, majority had perceptions and attitudes that were
neutral toward HIV testing (Hsieh et al., 2009). On the contrary, providers with more
favorable attitudes and beliefs toward HIV testing were likely to encourage routine HIV
testing in their trainees (Berkenblit et al., 2012). To promote routine HIV testing in acute
care settings, measures must be taken to ensure providers’ attitudes toward HIV testing
are more positive. The discordance of perceptions between providers and patients toward
the HIV testing regulations resulting in patients’ willingness to be tested, but providers’
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failure to offer HIV test highlight the value of targeting providers’ attitudes in effort to
increase HIV testing.
Provider Behaviors and HIV Testing
Certain HIV testing behaviors among acute care providers impair their capacity to
perform routine HIV testing according to both the CDC’s HIV testing guidelines, and
practice-specific HIV testing programs. Cabana et al. (1999) indicated that providers’
behaviors that preclude HIV testing are beyond their responses to internal stimuli, and are
more to do with providers’ responses to external stimuli which has strong influence on
their actions regarding HIV testing. For instance, lack of financial incentives and
reimbursement related to HIV testing encouraged provider to adopt behaviors that
hindered routine HIV testing (DHHS, 2013; Shirreffs et al., 2012; Sison et al., 2013).
Other aspects of the external environment that influenced providers’ behaviors which
impacted HIV testing include: perceptions of local HIV prevalence, availability of HIV
testing programs, and provider-patient interaction experiences (Akhter et al., 2012;
Berkenblit et al., 2012; Messer et al., 2013). Among medical educators who did not
encourage their trainees to perform routine HIV testing, majority cited perception of low
prevalence of local HIV infection as the main barrier for not advocating routine HIV
testing (Berkenblit et al., 2012). Regarding provider-patient experience, black women
who had positive rapport with and perceived their providers to be supportive accepted
HIV testing and followed through with early entry into HIV treatment plans (Messer et
al., 2013). Among acute care facilities with established HIV testing programs, HIV
testing rates were noted to be high among providers who attested to the existence of such
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programs than those who did not (39% vs 13.3%) (Akhter et al., 2012). Improving
provider-patient experiences, establishing HIV testing programs, and informing providers
regarding local HIV prevalence are some of the measures that might promote HIV testing
in the acute care settings.
Provider Knowledge and HIV Testing
Knowledge of HIV testing is markedly low among many providers, even among
obstetricians caring for pregnant women (Hunter et al., 2012; Levison et al., 2012). It is
critical per the CDC recommendations that all pregnant women be tested for HIV to
mitigate vertical transmission. Using a self-administered survey among US Department
of Veteran Affairs (VA) providers, Arya, Bush, Kallen, Rodriguez-Barradas, and
Giordano (2013) indicated that almost 40% of the providers were not aware of the CDC
and VA HIV testing policies. However, the VA study by Arya et al. (2013) had only 55%
of participants returning completed surveys. Furthermore, among clinicians who were
expected to have competent knowledge of HIV testing regulations; primarily those that
practiced in HIV care, only 60% offered HIV testing to all patients ages 13 to 64 per
CDC regulations (McNaghten et al., 2009). Unawareness of HIV testing guidelines was
further highlighted by many providers who continued to utilize risk-based testing despite
recommendations for non-targeted HIV testing (Korthuis et al., 2011). However, when
providers received training on conducting sexual history and engaged those patients who
had increased risk of contracting STDs/HIV, researchers noted improved testing rates and
test acceptance (Lanier et al., 2014; Meanley et al., 2015). Whether the lack of
knowledge regarding HIV testing regulations among providers is due to personal factors
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or practice infrastructure, it must be corrected to bring real changes in the HIV testing
landscape.
Provider Characteristics and HIV Testing
In a random survey of the U.S. physicians using the American Medical
Association master file, researchers noted female providers were more likely to screen
patients for HIV (Bernstein, Begier, Burke, Karpti, & Hogben, 2008). Similar results
were found by researchers in two other studies that targeted ED physicians (a Arbelaez et
al., 2012; Hsieh et al., 2009). However, Bernstein et al. (2008) indicated that although
gender was not significant in ED-based HIV testing, female providers in pediatrics,
family, and internal medicine were more likely to offer HIV testing. These mixed
findings highlight why future researchers should determine the impact of gender on HIV
testing in the acute care settings. Another provider characteristic that might influence
HIV testing is the providers’ years of work-related experience: but, few studies have
explored this relationship especially in the acute care settings. Hsieh et al. (2009)
indicated that resident physicians with more than2 years of work-related experience
performed poorly regarding HIV testing, linkage to care, counselling, and support for
ED-based HIV testing compared to residents with less than 2 years of work-related
experience. In an Australian study researchers observed that providers who had
experience with HIV testing were comfortable providing rapid point-of-care testing than
those who had less experience (Conway et al., 2015). Findings from both studies
indicated that HIV- focused training resulted in improved provider attitudes toward HIV
testing. When providers’ race/ethnicity was considered, providers of African American
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and Hispanic descent were more inclined to offer HIV testing (Bernstein et al., 2008;
McNaghten et al., 2013). However, the extent to which providers’ race/ethnicity impacts
HIV testing in the acute care settings has not been thoroughly studied. Regarding age and
HIV testing, Bernstein et al. (2008) and McNaghten et al. (2013) noted d that ED
providers younger than 40 years had a higher probability of offering HIV testing than
older ED providers. Regarding provider specialty and HIV testing, there were mixed
results with respect to the frequency of HIV testing in various settings. In a survey of
physicians, nurse practitioners (NPs), and physician assistants (PAs) using data from the
CDC Medical Monitoring Project (MMP), McNaghten et al. (2013) noted that being a NP
resulted in higher likelihood of offering HIV testing compared to being a physician.
Similar findings were noted by Fincher-Mergi et al. (2002) who indicated that NPs were
25% more likely to encourage patients to undergo HIV testing in ED compared to MDs
16% and registered nurses (RNs) 7%. However, using an observational design and data
from a community-based urgent clinic linked to Massachusetts General Hospital, Bender
Ignacio et al. (2014) indicated that compared to physicians, NPs and PAs were less likely
to order HIV testing on their patients. Furthermore, McNaghten et al. (2013) indicated
that among practitioners who participated in the MMP survey, emergency physicians,
internal medicine, and pediatricians were less likely to order HIV test compared to family
or general practitioners.
Type of HIV Test
Although providers have discretion of ordering any type of diagnostic test, the
type of HIV test available might influence testing rates in the acute care landscape. Bass
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et al. (2011) noted in a web-based cross-sectional survey that most primary care and
internal medicine physicians lacked access to rapid HIV testing kits, and among
providers who had access to rapid testing kits, HIV testing was considerably higher in
their practices. There are differences in processes and outcomes between point-of-care
HIV testing and the standard laboratory, and the differences needs to be considered when
evaluating the success of HIV testing in the acute care settings (White et al., 2011). It is
important especially in the ED where some patients may not return for test results, or may
not be reached once discharged, to prioritize utility of the point-of care rapid HIV testing.
There is a lack of ample research that addresses the impact of provider type and provider
characteristics on the rate of HIV testing in the acute care settings. Findings from various
studies were inconclusive regarding the differences in HIV testing rates among different
provider- specialties in the acute care settings. I intended to fill that gap in the current
study.
Summary and Conclusions
HIV infection remains a public health concern due to persistent occurrence of new
HIV infections, a trend that is propagated by a significant number of persons who lack
knowledge of their seropositive status. HIV testing has not been routinized in many
health care settings as recommended by the CDC, a problem that presents marked
challenges in the effort of preventing HIV/AIDS. Despite recommendations from the
CDC, USPTSF, and several states that all people’s ages 13 to 64 should be tested for HIV
infection in health care settings, many providers do not offer HIV testing to their patients.
Moreover, provider related barriers, system-wise barriers, and patient specific barriers
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impede HIV testing in the acute care settings. Research has shown that an overwhelming
majority of patients readily accept HIV testing when offered, but, many providers in the
acute care settings fail to perform HIV testing. Many patients do not get tested despite
several prior encounters with health care providers. Nearly 74% of providers in the MMP
survey indicated that most patients came for consultations after experiencing HIV-related
symptoms (Mgbere et al., 2014). Although the benefits associated with timely initiation
of treatment for HIV infection are well documented, HIV testing continues to be
underutilized in the acute care settings. Provider attitudes toward HIV testing, testingrelated behaviors, and the lack of HIV testing knowledge are some of the factors that
preclude HIV testing in the acute care settings.
Current literature addressing HIV testing in the acute care settings yielded mixed
results with regards to the impact of provider type and provider characteristics on HIV
testing. For example, the impact of provider age, race/ethnicity, gender, and years of
experience on HIV testing in the acute care settings is understudied. Examining how
provider characteristics impact HIV testing in the acute care settings is an area that needs
more research. There are unanswered questions regarding the effectiveness of targeted
versus non-targeted HIV testing approaches. Therefore, many providers who
underperform in HIV testing tend to utilize the targeted HIV testing approach. To end
HIV/AIDS epidemic and associated complications, all people who are infected with
HIV/AIDS must have access to HAART, and they must also achieve marked viral
suppression. The literature review indicated that HIV testing is underutilized particularly
in the acute care settings despite recommendations that all patients ages 13 to 64 should
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be offered routine HIV testing. Without a robust HIV testing program in most healthcare
settings, it will remain challenging to significantly diminish the incidence of HIV
infections. Thus, implementation of routine HIV testing in the acute care settings could
reduce the number of people who lack knowledge of their seropositive status, and more
importantly, it has potential to mitigate the transmission of HIV. In chapter 3 I discuss the
methodology for the current study.
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Chapter 3: Research Method
The purpose of this quantitative study was to examine the relationships between
HIV testing and provider type, knowledge, attitudes, behaviors, and barriers to HIV
testing in the acute care setting. In this chapter, I discuss the methods and procedures
used to collect data, including the sampling approach. I also discuss the appropriateness
of the research design, the instrument used, and the data collection and analysis
techniques.
Research Design and Rationale
It was not possible to use the experimental design in this study given that the
exposure and outcome of interest had already occurred. An observational design was the
most appropriate approach for this study. Likewise, a cohort study was not appropriate
due to the time and resource constraints, and neither was the case-control study as there
was no control group. A cross-sectional study design was used. This type of study design
is appropriate when the researcher is interested in the outcome prevalence and in the
identification and description of associations (Dorak, 2006; Mann, 2003; University of
Southern California, 2015). Because I intended to examine the performance of HIV
testing in a specific acute care setting in relation to a variety of provider-related
characteristics using a questionnaire, the cross-sectional design was appropriate because
it allowed for the estimation of the prevalence of the target outcome and the description
of the associations between the risk factors and the outcome of interest. In most of the
related literature, researchers used the cross-sectional design. I had no control over the
exposure assignment and site characteristics and therefore could not establish temporality
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or causation. Considering the problem statement and the research questions, I could only
investigate and describe the associations between risk factors and the outcome of interest.
The cross-sectional design cannot be used to determine cause and effect; however, its
utility for the investigation and description of the relationship between the exposure and
outcome of interest is important with regards to public health planning (Mann, 2003).
Moreover, the strengths of the cross-sectional design lie in its potential to provide a
snapshot of current events and associated characteristics (Dorak, 2006; Mann, 2003;
University of Southern California, 2015). A robust snapshot of current events is
important for policymakers and program administrators who often make decisions on
resource allocations based on prevailing conditions.
Methods
Participants were recruited from a local area hospital located in a southwestern
suburb of Chicago, IL. The hospital is a 480-bed general medical and Level II trauma
hospital that provides university-level services to patients. Its most current annual
admissions count based on the 2015 census was approximately 24,000, with more than
71,000 annual ER visits. The medical center has more than 600 medical staff (physicians,
PAs, and NPs) who provide medical care in various capacities. Providers were eligible to
participate in this study if they regularly provided medical care to HIV-free patients aged
13 to 64 years. The sampling frame included all medical care providers who were
working in the medical center at the time of the study. It was not feasible to include the
entire sampling frame in the study. Therefore, a sample of the medical providers was
drawn for the study.
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Sampling and Sampling Procedure
I used the convenience sampling technique, which is a type of nonprobability
sampling method. It was the most feasible method of sampling that could be used for this
study as it is cost-effective, swift, and provides easy access to the target population.
Probability sampling techniques are favored in empirical research because results
obtained using representative samples are thought to have high validity, reliability, and
generalizability (Forthofer, Lee, & Hernandez, 2007; Laerd Dissertation, 2012).
However, the popularity of the convenience sampling technique was evident among
several studies in the literature reviewed, particularly studies that focused on the similar
problem. Even though convenience sampling is a nonprobability sampling method, it is
of good value to a researcher, especially when the target population is homogenous on
different levels and the measurement variability is likely to be low (Aaker & Sengupta,
2000; Strizhakova, Coulter, & Price, 2008). Given that the composition of the
participants in this study was homogeneous, there might not have been a major difference
that could be attributed to the lack of random sampling. Opponents of convenience
sampling argue that it is difficult to replicate empirically (Peterson & Merunka, 2014).
Despite its limitations, the convenience sampling technique provided me with a solid
alternative for the study.
Participants were identified from the hospital master list where all the providers
and their contact information are maintained. I contacted the hospital administration staff
member who provided access to a master e-mail list that was used to determine which
participants could receive the survey questionnaire based on the eligibility criteria.
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Participants were eligible to be included in this study if they were over 18 years of age;
were NPs, PAs, or physicians with authority to order an HIV test; worked in the acute
care setting; and provided direct medical care to non-HIV patients aged 13 to 64 years.
Non-provider participants as well as participants who worked in psychiatry were
excluded from the study. Participants self-reported on key variables contained in the
survey questionnaire. A participant information sheet accompanied the survey
questionnaire, and participants’ consent was implied by their participation in this study.
There was no compensation provided to participants for participation in the study.
Power Analysis and Sample Size
The size of the sample that was needed for this study was based on the alpha or
the level of significance, the desired power of the study, and the effect size (Cochran,
1997; Ellis, 2010; Kadam & Bhalerao, 2010). Most researchers commonly set the alpha
at 0.05 and the margin of error at 5% (Bartlett, Kotrlik, & Higgins, 2001; FrankfortNachmias & Nachmias, 2012). The effect size is the degree of difference between the
study groups, and a medium effect size is recommended (Ellis, 2010; Kadam & Bhalerao,
2010). When a large effect size is expected, the required sample size is smaller, whereas
an expectation of a small effect size requires a large sample size (Kadam & Bhalerao,
2010). Type II error (β) is committed when there is failure to detect a difference when
one exists. Statistical power is the likelihood that a study will detect a difference when
one exists. Most researchers set β at .20, which is power of 80% (1- β) (Ellis, 2010;
Kadam & Bhalerao, 2010). In keeping with the tradition of most researchers, I set the
alpha at 0.05, power at 80%, and effect size at medium.
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To determine the sample size for this study, I conducted an a priori power
analysis using GPOWER 3.1.9.2 software (Buchner, Erdfelder, Faul, & Lang, 2013). The
GPOWER software is a sample size calculating tool available in the public domain. The
parameters entered in the GPOWER software were as follows: test family = F test,
statistical test = linear multiple regression, effect size = 0.15 (medium), alpha = 0.05,
power = 0.80, and number of predictors = 4. The results of the power analysis showed
that the total sample size needed for this study was 85. The literature review revealed that
most researchers used large sample sizes (62-220) for similar studies.
Recruitment Procedures, Participation, and Data Collection
After I obtained IRB approval from both institutions (Walden University and the
study facility), I attached a participant information letter to the survey questionnaire
(Appendix C) that was distributed to all eligible participants. The questionnaire was emailed by the administrative personnel to all eligible participants using the e-mail
addresses on the master list. Participants were given the opportunity at the beginning of
the questionnaire to read the embedded consent form and decline participation if they so
wished. Participants’ consent was implied by their participation in this study. To increase
participation, I distributed a paper version of the questionnaire to the participants during a
scheduled quarterly provider meeting. This was convenient for participants who preferred
a paper-based questionnaire. Prior to the distribution of the survey questionnaire, I made
an announcement in the meeting reminding providers that a paper-based questionnaire
would be circulated in the following meeting, and those who preferred would complete
the survey at that time. Participants were asked to self-report their age in years, gender
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(M/F/Transgender), number of years in practice, race/ethnicity (selected from provided
choices), specialty, and attitudes and beliefs about HIV testing in the acute care setting.
In addition, participants were asked to select from a list provided in the questionnaire the
types of barriers that hindered them from conducting routine HIV testing. Furthermore,
participants were provided with contact information on how to reach me or the IRB
representatives with questions or any other concerns related to this study. Two weeks
after the initial e-mail, I sent a follow-up e-mail to participants reminding them to
complete and return the survey questionnaire if they were planning on participating in the
study. At the end, I sent a thank-you e-mail to participants acknowledging their
participation in this study. Completed paper-based surveys were collected, and e-mailbased responses were forwarded to me by the administrative personnel for analysis.
There were no post survey interviews or debriefing provided to participants after the
completion of the study.
Instrumentation
A survey questionnaire was the main instrument used for data collection
(Appendix C). A large portion of the data collected was self-reported through the
questionnaire. In the social sciences field, the use of a questionnaire is popular, especially
among researchers involved in health behavior studies. Many researchers are conducting
surveys to investigate how knowledge, attitude, behavior and practice (KABP) interplay
in the wider landscape of program design, implementation, and evaluation (Green, 2001;
Hausmann-Muela, Ribera, & Nyamongo, 2003; Manderson & Aaby, 1992). However,
other researchers have raised concerns about the robustness of the KABP approach in
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surveys, as data collected using this system is susceptible to misinterpretation and
misapplication (Caldwell, Caldwell, & Quiggen, 1989; Cleland, 1973; Green, 2001;
Manderson & Aaby, 1992). Despite these concerns, the utility of the questionnaire as a
method of data collection is well established in the research community, and was an
appropriate method to use in this study.
The questionnaire used in this study was adopted from two separate instruments:
(a) the Public Health-Seattle & King County (PHSKC) HIV Testing Survey: Knowledge,
Attitudes and Practices (Shirreffs et al., 2012) and (b) the Society of General Internal
Medicine (SGIM) HIV Testing Survey (Korthuis et al., 2011). To design the
questionnaire for this study, most of the items used came from the first instrument, and a
small number of items were included from the second instrument. Both instruments were
designed to obtain data about medical providers’ knowledge, attitudes, demographics,
and behaviors as related to the practice of HIV testing.
The authors of the SGIM HIV Testing Survey developed their instrument by
borrowing from previous research on barriers to HIV testing and from the literature that
addressed the influence of primary care providers’ beliefs, attitudes, and knowledge on
HIV testing (Bashook, Edison, Sullivan, Bass, & Sosman, 2008; Burke et al., 2007).
Furthermore, Korthuis et al. (2011) conducted a pilot study in which items in the
questionnaire were tested for consistency before being included in the SGIM HIV testing
survey. The SGIM HIV testing survey was developed in 2008, and other researchers
engaging in the HIV testing discourse have utilized the SGIM survey in their studies

63
(Arya et al., 2014; Bass et al., 2011). However, the authors of the SGIM HIV testing
survey did not establish reliability and validity for this instrument.
The authors of the PHSKC HIV testing survey also designed their instrument
using data from existing literature, specifically the literature associated with HIV testing
in healthcare settings. Items in this instrument were adopted from other instruments in the
literature where researchers addressed similar research problems (Burke et al., 2007;
Korthuis et al., 2011; Jain, Wyatt, Burke, Sepkowitz, & Begier, 2009). The PHSKC HIV
testing survey was used to collect data from the participants on key demographics, testing
approaches, attitudes, and beliefs related to HIV testing (Shirreffs et al., 2012). Similarly,
the authors of this instrument did not establish reliability or validity for their instrument.
Permission to use these instruments or alter them as appropriate was obtained from the
relevant authorities (Appendix A & B).
Operationalization of Study Variables
HIV Testing
The dependent variable was HIV testing. The HIV test is used to detect antibodies
to or HIV itself in a person’s whole blood or saliva. I wanted to know the proportion of
HIV testing that was being offered to patients, its frequency, and whether providers were
ordering routine HIV tests. This information was gathered using the following survey
questions:
1. Have you ordered any HIV tests for your patients in the past 30 days?
Responses were yes or no.
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2. In the past six months, approximately how many times did you order an HIV
test? The possible responses were none, 1-5, 6-10, 11-24, and more than 25.
3. In the past 12 months, approximately how many patients did you diagnose as
HIV positive? Responses were none in the past year, 1, 2-5, 6 or more, and
never in my career.
The scale associated with this variable would be either ratio (Questions 2 and 3) or
categorical (Question 1). Ordering no HIV test or ordering fewer tests has been
associated with lack of routine HIV testing (McNaghten et al., 2013).
Provider Characteristics/Demographics
Age: The Number of years lived from birth to the time of participation in this
study. This variable was obtained through self-report and it is a ratio variable.
Sex: This variable is also a covariate and represents the participant’s gender at
birth. However, there is an option for transgender among the responses provided (female,
male, and transgender). This is a categorical variable.
Years of experience: This is the total number of years that a participant has been
providing medical care. This was measured starting from the time the participant
completed training and started working (including fellowship). Participants were asked to
record in the questionnaire the year that they finished training. This is a ratio variable.
Race/ethnicity: This is the distinctive groups onto which people can be grouped
based on certain characteristics such as shared history, physical features, and culture.
This is also a categorical variable. Participants were asked to indicate the race they
belonged to, and the possible responses were; Spanish/Hispanic/Latino; White;
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Black/African-American; Native American/Alaskan Native; Asian, Pacific
Islander/Hawaiian Native, and Other.
Types of Providers
This is the distinction of medical personnel based on the type of licensure, the
nature of work performed, and accreditation (Agency for Healthcare Research and
Quality, n.d). Participants were asked to indicate their provider category, and the possible
responses were; Nurse Practitioner; Physician Assistant; or Physician. These providers
are licensed and have the authority to order HIV test. This is also a categorical variable.
Clinical Specialty
Clinical specialty is a branch of medical practice and represents an area of focus
under which providers operate or have additional training. Participants were asked to
choose their specialty from the list provided, and the possible responses were; Emergency
Medicine; Family Medicine; Geriatrics; Internal Medicine; Obstetrics/Gynecology;
Pediatrics; Surgery, and Other (Specify). This is also a categorical variable.
Knowledge of HIV Testing Regulations
Knowledge of HIV testing regulations is the extent to which participants were
aware of the most current state (IL) and federal (CDC) HIV testing regulations.
Knowledge of HIV testing regulations was examined using two survey items; # 13
(Check one answer that best reflects the CDC’s recommendations) possible responses
included; test all patients between 13-64 years of age for HIV regardless of risk factor
history; test all patients for HIV if the prevalence of HIV in your community is greater
than 0.1%; test those patients who report HIV risk factors; test those patients who display
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signs or symptoms of AIDS, and all the above. # 14 (Please answer the following
True/False questions about the current IAC rules) possible responses included; the IAC
requires informed consent for HIV testing; the IAC requires written consent for HIV
testing; the IAC requires providers to offer posttest prevention counseling to all patients;
the IAC requires providers to document a pregnant patient’s refusal of an HIV test, and
the IAC requires opt-out testing. The participants who correctly identified the right
answers in these two items were deemed knowledgeable of HIV testing regulations, and
those who did not, were considered lacking that knowledge.
Attitude
Attitude is “an enduring organization of beliefs, feelings, and behavioral
tendencies toward socially significant objects, groups, events or symbols” (Hogg &
Vaughan, 2005, p.150). In this study attitude is a measure of participants’ perception of
the HIV testing guidelines. Participants were asked to respond ‘Yes’ or ‘No’ to the
following questions; I believe offering HIV testing to all individuals ages 13 to 64
regardless of risk will improve public health in my community; I believe offering routine
HIV testing to all patients regardless of risk will benefit my patients; and I believe
offering routine HIV testing to all patients regardless of risk will decrease my ability to
meet their other medical needs. Believing that routine HIV testing is not appropriate, and
opposition to, or failure to comply with established HIV testing guidelines constituted
negative attitude. Believing that routine HIV testing is beneficial, and supporting the
practice of HIV testing constituted positive attitude. Attitude was also determined from
participants’ responses to items in the questionnaire that addressed HIV testing barriers.
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Testing Behaviors
A behavior is the overall response generated or actions undertaken by a person to
external or internal stimuli. A behavior can affect both the person who adopts that
behavior, and the social environment. In the HIV testing landscape, behavioral tendencies
are not only a result of providers’ actions but also are due external elements that cause
providers to adopt behaviors that hinder HIV testing (Cabana et al., 1999). Testing
behaviors were determined by the extent to which certain factors e.g. staffing, type of
HIV test, and availability of testing protocols influenced participants’ tendencies with
respect to offering HIV test. Participants were asked to indicate their personal approach
to HIV testing, and the type of test they utilized from the choices provided in the
following survey questionnaire items:
(a) # 3 Is there an HIV testing policy at your primary work location? Possible
responses included; Yes, routine testing, Yes, targeted testing based on a
patient’s risk factors, No, my practice does not have a HIV testing policy, HIV
testing is prohibited in my practice, I don’t know, and Other.
(b) #4 Which of these describe how you personally approach HIV testing with
your patients? (check all that apply). Possible responses included; I test all my
adolescent and adult patients at their first visit, I test patients who report HIV
risk factors, I test patients who have signs or symptoms of HIV/AIDS, I test
any patient who asks for an HIV test, and I never order HIV tests.
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(c) # 8 I estimate the prevalence of HIV-infection in the population my clinic
serves are; possible responses included; < 0.1%, 0.1%-0.9%, 1.0% - 4.9%,
5.0% - 10%, and > 10%).
Furthermore, participants were asked to indicate whether they strongly disagreed,
disagreed, agreed, strongly agreed, or were undecided with statements about the influence
of reimbursement, time, and the perception that their patients have low HIV risk on HIV
testing. Survey item # 12; There are many reasons why providers may not offer routine
HIV screening in their practices, from the responses provided select whether you strongly
disagree, disagree, agree, strongly agree, or undecided.
Data Analysis Plan
Data analysis was based on the primary data that was collected using the survey
questionnaire. Participants self-reported on key variables, and their responses were used
to examine the relationships among target variables. The sample consisted of medical
providers with authority to order HIV test; those who primarily worked in the acute care
setting. The purpose of the study was to examine the relationship between HIV testing
(outcome variable) and provider type; characteristics; knowledge of HIV testing
regulations; beliefs and attitudes about HIV testing (predictor variables) in the acute care
setting. Descriptive statistics was used extensively to report on the basic features and
distribution of the data to allow patterns to emerge. For instance, frequency distributions
of provider characteristics, HIV testing, attitudes, beliefs, and practice characteristics
were presented using graphs and tables. Inferential analysis was undertaken to estimate
the associations and strength between the dependent and independent variables, and to
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draw conclusions on the population from the sample. Inferential statistics enabled the
researcher to determine whether the relationship between the variables of interest was
dependable (did not happen by chance), and would be generalized from this data to the
broader population. Following are the research questions and hypotheses that guided this
study:
Research Question 1: Is there a relationship between HIV testing and provider
types (NP, PA, MD) in the acute care setting?
H01: There is no relationship between HIV testing and provider types in the acute
care setting.
Ha1: There is a relationship between HIV testing and provider types in the acute
care setting.
Research question one was answered using the items in the questionnaire on
which participants were asked to indicate whether they had ordered the HIV test in the
past 30 days, and approximately how many times they ordered it. Using the Chi-square
test and multiple logistic regression with dummy variables, I sought to determine if there
was a statistically significant relationship between provider type, and ordering of the HIV
test. Results with a p-value less than .05 were deemed statistically significant, therefore,
the null hypothesis that there is no relationship between HIV testing and provider type
could be rejected.
Research Question 2: Is there a relationship between providers’ knowledge,
attitudes, and behaviors with respect to HIV testing and ordering HIV testing in the acute
care setting?
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H02: There is no relationship between providers’ knowledge, attitudes, and
behaviors with respect to HIV testing and ordering HIV testing in the acute care setting.
Ha2: There is a relationship between providers’ knowledge, attitudes, and
behaviors with respect to HIV testing and ordering HIV testing in the acute care setting.
Knowledge of HIV testing regulations was assessed by the proportion of correct
answers to the questions about the CDC and the IL state’s HIV testing regulations (items
# 13 & 14). Using the chi-square test and multiple logistic regression with dummy
variables, I sought to determine whether there was a statistically significant relationship
between the knowledge of HIV testing regulations and HIV testing. Attitudes toward
HIV testing were examined using the survey questionnaire items # 9 (I believe offering
HIV testing to all people’s ages 13 to 64 regardless of risk will improve public health in
my community); #10 (I believe offering routine HIV testing to all patients regardless of
risk will benefit my patients); and #11 (I believe offering routine HIV testing to all
patients regardless of risk will decrease my ability to meet their other medical needs). In
these items participants were asked to indicate ‘yes/no’ regarding their beliefs about the
importance of routine HIV testing. Positive responses were regarded as supportive of
routine HIV testing, whereas negative responses were regarded as opposed to routine
HIV testing. I used the Chi-square test to examine whether there was a statistically
significant association between attitudes toward HIV testing, and the ordering of HIV
testing. Moreover, I examined providers’ behaviors associated with HIV testing using
items in the questionnaire that asked participants to estimate local HIV prevalence, and
identify the type of HIV test used. Additionally, I assessed HIV testing behaviors using
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questions where participants were asked to indicate whether lack of reimbursement; low
staffing; time pressures; or lack of HIV testing policy were barriers to HIV testing in their
practices. The Chi-square test and the multiple logistic regression were used to determine
if there was a statistically significant relationship between participants’ HIV testing
behaviors and HIV testing. Results with a p-value less than .05 were deemed statistically
significant, therefore the null hypothesis that there is no relationship between providers’
knowledge, attitudes, and behaviors with respect to HIV testing and HIV testing in the
acute care setting would be rejected.
Research Question 3: Is there a relationship between provider-identified barriers
to HIV testing and HIV testing in the acute care setting?
H03: There is no relationship between provider-identified barriers to HIV testing
and HIV testing in the acute care setting.
Ha3: There is a relationship between provider-identified barriers to HIV testing
and HIV testing in the acute care setting.
Participants’ responses to item # 12 in the survey questionnaire provided data that
I used to determine the extent to which barriers represented an impediment to HIV testing
in the acute care setting. The relationship between identified barriers and HIV testing
were examined using the multiple logistic regression. The relationship between perceived
barriers and HIV testing were assessed by comparing participants’ responses on the fiveoptions Likert scale. Additionally, using the multiple logistic regression by entering
variables simultaneously, I examined demographic characteristics that could predict HIV
testing among study participants. Results were interpreted using confidence intervals,
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odds ratio, and percentages. Results with a p-value less than .05 were deemed statistically
significant, therefore the null hypothesis that there is no relationship between provideridentified barriers to HIV testing and HIV testing in the acute care setting would be
rejected. Data analysis was accomplished using the IBM SPSS software version 21.0
(IBM, 2011).
Variables such as age, gender, and race/ethnicity have been considered covariates
in relation to HIV testing. (Korthuis et al., 2011). Given that these variables have
predictive value in association with the outcome of interest, they were included as
covariates in this study. When multiple statistical tests and multiple hypotheses testing
are conducted concurrently, there is a likelihood of committing type I error and or
obtaining spurious findings (Schochet, 2008). There are several techniques that can be
used to address the multiple comparisons problem, and the utility of any of these
correction techniques will depend on the study design, research problem, and the type of
data (Schochet, 2008). I planned to use the Bonferroni procedure to account for the
multiple statistical tests when appropriate. Although the problem of multiple
comparisons can be overcome statistically, Saville (1990) cautioned against the practice
of adjusting for multiple statistical testing because it might lower a study’s statistical
power. There is a delicate balance that a researcher must exercise between committing
type I error vs. type II error. Therefore, the process of adjusting for multiple comparisons
should be cautiously undertaken.
Data cleaning and measures to address missing data are essential to ensure that
erroneous data entry and inconsistencies as well as incomplete and inaccurate data points
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are identified, corrected and or removed. This process is critical to the research endeavor,
because it enables researchers to improve data quality and avoid spurious conclusions. It
is common in survey research to encounter missing data due to incomplete entry, or nonresponse by participants. Therefore, steps should be taken to improve data quality, and
address the missing data.
I started by reviewing the data closely to identify the presence of any coding
errors. For example, if 1 = Male, 2 = Female, and 0 = missing, then an entry of 10 will be
erroneous. Secondly, I used frequency distribution tables to identify missing data.
Thirdly, I looked for any outliers in the data. Outliers can skew the data and lead to
overestimation or underestimation of exposure effects. Using the box plot and creating a
bar graph, I could identify if there were any outliers in the data. Like other studies that
rely on survey methods, unreasonable and inconsistent responses were a possibility in
this study. The use of cross-tabulation to compare participants’ responses and results
across variables is one way of removing inconsistencies. I coded missing or unknown
values as 999.
Threats to Validity
The goal of a researcher is to determine whether a relationship exists between
variables of interest in the paradigm of scientific inquiry and to reach a reasonable
conclusion as to whether exposure to some element leads to a certain outcome. This goal
is achieved when the researcher’s conclusion is accompanied by a high degree of
precision and validity. Lack of precision (introduction of random error) is a notable
problem especially in observational studies, a problem associated with sampling methods

74
and the techniques utilized for measuring variables (Carlson & Morrison, 2009; Rothman
& Greenland, 1998). Wide confidence intervals, small sample size, and high standard
deviations signal low precision. Lack of validity (introduction of systematic error or bias)
should be kept to a minimum. According to Rothman & Greenland (1998), a study is
considered valid when there are no systematic errors present (Systematic errors in
research may arise from instrumentation, or from the mistakes observers make when
taking measurements. Identifying possible sources of validity threats and implementing
strategies to avoid such threats is expected of all researchers.
Internal Validity Threats
Common sources of internal validity threats are: history, maturation, testing,
instrumentation, statistical regression, selection bias, mortality, and the selectionmaturation interaction (Campbell & Stanley, 1963). Internal validity threats undermine a
researcher’s confidence in concluding that a relationship exists between the exposure and
the outcome variables. Therefore, eliminating internal validity threats will enable the
researcher to make appropriate inferences. These are the possible internal validity threats
to this study:
History: The history threat is described as any external event during the study
period that might influence participants’ responses (Campbell & Stanley, 1963). For this
study, there is a possibility of an event such as an HIV outbreak or a conference related to
HIV testing which might influence participant responses. However, such an event could
not be forecasted. Participants were asked to report if they had attended a conference on
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HIV testing in the previous year, because such an occurrence might heighten participants’
awareness and knowledge of HIV testing regulations.
Maturation: This type of internal validity threat is described as the normal
change process that occurs within participants’ environment due to passage of time
(Campbell & Stanley, 1963). For instance, getting frustrated with answering a long
survey is an example of maturation threat. I utilized a short questionnaire to avoid this
type of internal validity threat.
Selection: Depending on the sampling methods, e.g. random versus nonrandom,
study participants may be similar or dissimilar during recruitment. Utility of nonrandom
sampling method may result in nonequivalent groups, which can lead to spurious
outcomes. However, the selection threat is a challenge more so to the two-group design
study (Indiana University, n.d.). It is possible that those who choose to participate in this
study were highly knowledgeable about HIV testing, and that could have affected the
outcome variable. Given that this study was a one group design with a homogenous
sample, the threat of selection was not anticipated.
Instrumentation: Bias may be introduced by the instrument used for measuring
the variables of interest. The lack of established validity and reliability for the two
instruments that informed the instrument used for this study may have undermined the
study’s internal validity. However, the results obtained using this instrument were
comparable with studies where researchers had used a similar instrument.
Subject mortality: Attrition results from loss of research participants due to
dying, dropping out or submitting incomplete survey questionnaires (Campbell &
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Stanley, 1963). Loss of subjects may lead to erroneous inferences and loss of power due
to a low sample size. I utilized oversampling strategy to ensure adequate participation and
responses in this study.
Other internal validity threats such as: compensatory rivalry, design
contamination, testing, resentful demoralization, and statistical regression (Indiana
University, n.d.) were less applicable to this study. The strength of this study depended
on its success in minimizing or avoiding systematic errors.
External Validity Threats
A researcher must first establish internal validity before ensuring external validity
(Campbell & Stanley, 1963). External validity is the degree to which results obtained in
one study could be generalized to other populations at different times and locations
(Campbell & Stanley, 1963; Carlson & Morrison, 2009; Rothman & Greenland, 1998). It
is important to obtain research outcomes that are externally valid so that results can be
generalized, thus facilitate evidence-based practice and limit resource waste. There are
several external validity threats such as: pre-test-treatment interaction, selectiontreatment interaction, multiple treatment interference, specificity of variables, treatment
diffusion, experimenter effects, and reactive effects (Western Oregon University, n.d.).
There were only 3 external validity threats that were relevant to this study.
Selection-treatment interaction: The selection-treatment interaction occurs
when nonprobability procedures are used to select participants for a study, or when
subjects self-select, therefore rendering the results to have low external validity (Western
Oregon University, n.d.). In this study a convenience sampling technique was used to
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reach participants, this being a nonprobability sampling method, generalizability of this
study is limited. However, given the time and resource constraints, I could not have
utilized more elaborate sampling methods. Additionally, most researchers in previous
studies used the convenience sampling technique.
Specificity of variables: When variables are not clearly defined and
operationalized, it is difficult to delineate the extent to which the study results can be
generalized (Western Oregon University, n.d.). In this study, operationalization and
definition of variables was consistent with information found in the literature review.
Experimenter effects: Sometimes participants may alter their responses or
behavior due to awareness of the researcher’s presence and actions, this phenomenon
might affect participants’ truthfulness and accuracy during the survey when providing
self-report responses. I was an employee in the same hospital that was the source of
participants in this study. This created a likelihood of bias because some participants may
have known or had a relationship with me. The problem of experimenter effects is
mitigated by using a double-blind approach; however, in this study double-blinding was
not applicable. I used a third-party survey entity (Survey Monkey) to address possible
experimenter effects. In addition, by ensuring that participants’ responses were
anonymous, I lessened the problem associated with experimenter effects.
Research studies with small sample sizes and those with unrepresentative samples
are very limited in their capacity to be generalized (Carlson & Morrison, 2009).
Repeating previous studies using similar methods and population is one way to confirm if
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the results from observational studies can be generalized to different population, periods,
and settings.
Statistical Conclusion Validity Threats
Statistical conclusion validity is the degree to which the conclusions reached by
the researcher are correct based on the data (Adams, 2008). Conclusion validity threats
are factors that might cause a researcher to reach erroneous conclusions about the
relationship or the strength of the relationship between the variables of interest. A
researcher can erroneously conclude from the data that a relationship exists between the
variables of interest when such relationship does not exist, and or fail to identify when a
relationship exists. In the next section, I discuss statistical conclusion validity threats
relevant to this study.
Low reliability of measures: A study with low reliability of measures which
might result from poorly constructed research questions and instruments, can lead to an
incorrect estimate of the relationship between the dependent and independent variables
(Adams, 2008). The instrument utilized in this study was designed from existing
instruments that have been used in the same field by researchers who addressed similar
problems and utilized similar research methods.
Low statistical power: A study with low statistical power is likely to result in an
incorrect conclusion that there is no relationship between the dependent and independent
variables. This represents committing a type II error; failing to identify a relationship
when one exists (Adams, 2008; Social Research Methods, 2006). Factors that can affect
the statistical power include: the sample size, the magnitude of the effect, and the
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statistical significance criterion. In this study, I attempted to attain a large sample size, I
used a medium effect size, and an alpha of .05.
Heterogeneity of respondents: A research sample comprised of heterogeneous
subjects can hinder a researcher from identifying a relationship or a true difference
between target variables (Adams, 2008; Social Research Methods, 2006). One approach
to overcome this threat is by matching study participants. In this study, I utilized
homogenous participants, therefore the threat associated with heterogeneity of
respondents was not anticipated.
Fishing and the error problem: This conclusion validity threat occurs when
multiple statistical analyses are conducted using the same data. Committing the error can
lead to incorrect conclusions that a relationship exists between the dependent and
independent variables. To remedy this threat, I made adjustment using the Bonferroni
correction when appropriate.
Violation of statistical tests assumptions. Most statistical tests have stipulated
assumptions that must be met before a researcher can use them. Violation of the
assumptions could lead to overestimation or underestimation of the effect size and
significance (Adams, 2008; Social Research Methods, 2006). In this study, I evaluated
the appropriateness of each statistical test to ensure that assumptions were met before I
used them. I was prepared to utilize alternative statistical tests to avoid violating
assumptions and thus compromising the results.
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Ethical Procedures
Ethics is an integral aspect of any scientific endeavor, and one that must be
adhered to by all researchers. Historically ethics in research is an area that has received
great emphasis to ensure that human and animal subjects are protected. Ethical
procedures are particularly essential in research to ensure that:
1. Any research is conducted to higher standards and free of inaccuracies,
falsification, coercion, and dishonesty (Resnik, 2011).
2. All researchers involved in any research undertaking are equally recognized
and rewarded (Resnik, 2011).
3. The public is safe from researcher actions or misconduct (Resnik, 2011).
Knowing the critical role ethics plays in scientific research, I conducted this study in
accordance with established ethical guidelines; federal, state, and those established by the
involved institutions. Following are various ethical concerns related to this study, and
possible remedial procedures:
Before commencing the process of collecting data, I obtained permission from the
Walden University IRB (# 07-08-16-0342839) and the IRB from the institution where
this study was based. Letters granting permission to conduct this study were received
from the IRB in both institutions. In addition, a letter of cooperation was procured from
the research site granting authority to access subjects’ emails and to send them invitations
to participate in the study.
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Recruitment and Participation
The recruitment procedures were fair and free of prejudice. Participants were
protected from any possible harm even though this study was not expected to cause any
harm. Participation was voluntary; participants were informed that they were under no
obligation to participate, and that they could withdraw at any given time. Participants
received the survey questionnaire through their work emails and physically at the
quarterly providers’ meeting. No other contact methods were sought. Additionally,
participants’ responses were anonymous, therefore eliminating any risk of linking
participants to their answers. The informed consent was incorporated in the survey
questionnaire.
Data Collection
I did not collect and or use any personal health information (PHI), this was
necessary to ensure confidentiality. Nevertheless, I exercised great caution to ensure that
any data collected were safeguarded and properly handled. Participants were not
pressured or coerced in any way for the purposes of collecting data. The researcher was
the only person with access to the collected data which was password protected. Data will
be destroyed after five years.
Research in the Workplace
Because I conducted this study in the same organization that I worked for, there
was a certain level of ethical concern entailed. Risks that could undermine the integrity
and rigor of the research findings due to utilizing workplace resources and participants
demanded careful consideration. Participants who work at the same facility might be
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anxious to participate in the study if they perceive that their personal information is not
going to be safeguarded. In this study, however, I did not utilize PHI. First, I negotiated
with the organization at the outset to ensure that I owned the data that was collected.
Secondly, I separated my research role from my employment role. Work relationships
and performance were not allowed to influence the research process. Thirdly, I made it
clear to the participants that they were under no pressure to participate or complete the
survey questionnaire, and that they could cease at any time without any repercussions.
Fourthly, I made provisions in the questionnaire that guaranteed participants’ privacy and
confidentiality.
Summary
I described in detail how the study was conducted, noting the procedures, design,
participants, and the methods. Using the quantitative approach and the cross-sectional
design, I sought to examine the determinants of HIV testing in the acute care setting. The
cross-sectional design was appropriate for this study for finding the prevalence of the
target phenomenon, and for investigating associations between target variables and the
outcome of interest. This design is commonly utilized in the epidemiology field and in
studies related to public health. The review of the literature indicated that routine HIV
testing and diagnosis optimization were lacking in acute care settings: thus, the
population and setting of this study were aligned with the research problem and purpose.
Given the resources and time constraints, I chose the convenient sampling technique,
where participants were asked to voluntarily complete an anonymous survey
questionnaire. The survey questionnaire was designed from existing instruments that
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were constructed to study similar research problems. Once I collected the data, I analyzed
data using the IBM SPSS software version 21.0 (IBM, 2011), the multiple logistic
regression, and the chi-square test. The strength of this study, generalizability of its
findings, and my capacity to make statistical inferences depended on successful
elimination of validity threats. More importantly, I conducted this study in accordance
with established ethical standards, and the permission from appropriate IRBs. In chapter
4, I present the results from this study.
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Chapter 4: Results
The purpose of this cross-sectional study was to examine the relationships
between HIV testing and provider type, knowledge, attitudes, and behaviors regarding
HIV testing in the acute care setting. I also examined the relationship between provideridentified barriers to HIV testing and HIV testing in the acute care setting. In this chapter
I present the statistical analysis of the data and the study results. The three research
questions and hypotheses that guided the study are as follows:
1. What is the relationship between HIV testing and provider type (nurse
practitioner [NP], physician assistant [PA], physician [MD]) in the acute care
setting?
H01: There is no relationship between HIV testing and provider type (nurse
practitioner [NP], physician assistant [PA], physician [MD]) in the acute care
setting.
Ha1: There is a relationship between HIV testing and provider type (nurse
practitioner [NP], physician assistant [PA], physician [MD]) in the acute care
setting.
2. What is the relationship between HIV testing and providers’ knowledge,
attitudes, and behaviors regarding HIV testing in the acute care setting?
H02: There is no relationship between HIV testing and providers’ knowledge,
attitudes, and behaviors regarding HIV testing in the acute care setting.
Ha2: There is a relationship between HIV testing and providers’ knowledge,
attitudes, and behaviors regarding HIV testing in the acute care setting.
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3. Is there a relationship between HIV testing and provider-identified barriers to
it in the acute care setting?
H03: There is no relationship between HIV testing and provider-identified barriers
to it in the acute care setting.
Ha3: There is a relationship between HIV testing and provider-identified barriers
to it in the acute care setting.
Data Collection
Data were collected using a survey questionnaire that was distributed to all
participants who provided regular medical care to HIV negative patients, were 18 years
and older, and worked in the acute care setting. Data were collected over a period of 3
weeks (September 15 to October 7, 2016). A total of 600 participants received the survey
questionnaire either through e-mail or paper; 20 participants completed the e-mail
questionnaire and 68 participants completed the paper-based questionnaire, resulting in a
survey completion rate of 14.6%. Of the returned paper-based surveys, four were not
filled out completely and were not included in the data analysis. Also, four participants
were disqualified from the online survey because of answering no to the eligibility
questions (Do you regularly provide direct patient care to HIV-negative individuals
between the ages of 13 and 64 years old? Are you an MD, PA, or NP with authority to
order HIV tests at your practice?). There were no discrepancies in data collection from
that described in Chapter 3. The sample size (N = 88) was adequate, as an a priori sample
size calculation yielded an N of 85 to have 80% power.
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Results
Descriptive Statistics
The sample included 47 female, 40 males, and 1 transgender participant.
Participants’ age ranged between 25 and 61 years with a mean of 43.6. In this sample,
age was normally distributed. Most of the participants were MDs (51.1%). Participants’
work-related experience ranged from 1 to 26 years, and most participants had between 6
and 10 years of work-related experience. Most participants were Caucasian (59%). All
participants who completed the survey questionnaire indicated that they provided medical
care to HIV negative patients between the ages of 13 and 64 years within the study site.
Considering the distribution of age, gender, race, education, work-related experience, and
provider type, the sample was representative of the population. A summary of
participants’ gender, provider type, race, and experience is presented in Table 1.
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Table 1
Demographics (N = 88)
Factor

Category

n

%

Race

White
Black/AA
Asian
Pacific
Hispanics

52
12
14
1
9

59.1
13.6
15.9
1.1
10.2

Gender

Male
Female
Transgender

40
47
1

45.5
53.4
1.1

Type of provider

Nurse practitioner
Physician assistant
Physician

22
21
45

25.0
23.9
51.1

Experience

1-5 years
6-10 years
11-15 years
16-20 years
>20 years
999 missing

23
35
10
14
5
1

26.1
39.8
11.4
15.9
5.7
1.1

Descriptive statistics were obtained using univariate analyses. Most providers
specialized in emergency, family, and internal medicine, specialties that have some
contact with most patients who visit the hospital. When considering the work setting
where participants provided medical care, 12% of respondents worked in the ambulatory
clinic or office, 64% worked in the hospital inpatient unit, and 12% worked in the
hospital emergency room. All the respondents who worked in the ambulatory clinic or
office worked in the hospital inpatient concurrently. A summary of participants’ primary
clinical specialty is presented in Table 2.
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Table 2
Clinical Specialty (N = 88)
Frequency

%

Emergency medicine

12

13.6

Family medicine

33

37.5

Geriatrics

5

5.7

Internal medicine

13

14.8

Obstetrics/Gynecology 4

4.5

Pediatrics

3

3.4

Surgery

5

5.7

Other

13

14.8

Total

88

100.0

Table 3 presents factors related to HIV testing, including whether there was an
HIV testing policy at the participants’ practices, the number of HIV tests ordered in the
previous 30 days and the previous 6 months, the number of cases diagnosed with HIV in
the past 12 months, and the participants’ estimation of the local HIV prevalence.
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Table 3
HIV Testing and Prevalence (N = 88)
Factor

Category

Number

%

HIV testing policy

Routine testing
Targeted testing
No testing policy
Testing prohibited
I don’t know

5
61
12
1
9

5.7
69.3
13.6
1.1
10.2

HIV test in the past 30 days

Yes
No

25
63

28.4
71.6

# HIV diagnosed in the past 12 months

None
One
2-5
Never

67
12
5
4

76.1
13.6
5.7
4.5

HIV tests past 6 months

None
1-5
6-10
25 or more

42
39
6
1

47.7
44.3
6.8
1.1

HIV prevalence estimation

< 0.1%
0.1%-0.9%
1.0%-4.9%
5.0%-10%
>10%

23
20
31
12
2

26.1
22.7
35.2
13.6
2.3

Table 4 includes participants’ responses regarding their knowledge of the 2006
CDC guidelines for HIV testing. Almost half (48.9%) of participants failed to correctly
identify that all the responses were included in the CDC guidelines.
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Table 4
CDC Recommendations (N = 88)
Number

Percent

Valid
Percent

Test all patients 132

2.3

2.3

1

1.1

1.1

20

22.7

22.7

20

22.7

22.7

All the above

45

51.1

51.1

Total

88

100.0

100.0

65 years
Test all if prevalence
>0.1%
Those who report
HIV risk factors
Those displaying
signs/symptoms of
AIDS

When participants were asked about the 2012 Illinois Administrative Code (IAC)
HIV testing revisions, 73.9% correctly indicated that the IAC requires informed consent
for HIV testing, 38.6% correctly indicted that IAC does not require written consent for
HIV testing, 46.6% correctly indicated that IAC does not require posttest prevention
counseling to patients, 58% correctly indicated that IAC requires providers to document a
pregnant woman’s refusal to take an HIV test, and 62.5% correctly indicated that IAC
requires nontargeted HIV testing unless patients opt-out. However, when participants
were asked to indicate whether the recent IAC revisions would increase HIV testing in
their practices, 35.2% responded that they were unlikely to increase HIV testing, 56.8%
responded they were likely to increase HIV testing in their practices, and the remaining
8% were undecided or indicated that the question did not apply to them.
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Participants were asked to indicate the extent to which certain barriers hindered or
limited the offering of HIV testing in their practices. Over half (53.4%) agreed with the
statement that they did not have enough resources to perform HIV testing as
recommended, while 44.4% disagreed with that statement. Nearly three-fourths of
providers (72.8%) agreed with the statement that HIV testing was hindered or limited due
to concerns about reimbursement, while17% disagreed. Only 29.5% of providers
indicated that they did not have enough time to conduct HIV testing, and only 9.1%
indicated that they did not feel comfortable discussing HIV, sexual behaviors, or drug use
with patients. However, 60.2% of providers agreed with the statement that the pretest or
risk-reduction counseling was time consuming and/or burdensome, and 62.5% agreed
with the statement that the consent process was time consuming and/or burdensome.
Many respondents (73.8%) indicated that they did not perform routine HIV testing,
because they thought that the risk of HIV infection among their patients was low. Only a
small number of participants (12.5%) indicated that they conducted routine HIV testing
for all adolescents and adult patients without any barriers.
Other known risk factors for HIV/AIDS infection include lack of condom use,
having multiple sexual partners, injection drug use, and men who have sex with men.
However, 45.5% of providers did not ask patients about condom use or number of sexual
partners, 17% did not ask patients about history of STDs, 29.5% failed to inquire of their
male patients whether they engaged in sex with other men, 45.5% did not ask female
patients about their pregnancy history, and 17% did not ask patients about injection drug
use.
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Data Analysis
Data analysis with respect to the research questions and hypotheses is presented in
the following section:
Research Question 1
Research Question 1: What is the relationship between HIV testing and provider
type (NP, PA, MD] in the acute care setting?
H01: There is no relationship between HIV testing and provider type (nurse
practitioner [NP], physician assistant [PA], physician [MD]) in the acute care setting.
Ha1: There is a relationship between HIV testing and provider type (nurse
practitioner [NP], physician assistant [PA], physician [MD]) in the acute care setting.
To answer this research question, I analyzed data using binomial logistic
regression, with HIV testing being the dependent variable and age, gender, experience,
and provider type being the independent variables. To utilize the binomial logistic
regression procedure, there are four statistical assumptions that must be met:
1. The dependent variable is dichotomous and has mutually exclusive categories.
2. There are one or more independent variables that are either continuous or
categorical.
3. Observations are independent.
4. There is a linear relationship between any continuous independent variables
and the logit transformation of the dependent variable (Field, 2013: Laerd
Statistics, 2013). The logit is a link function. Therefore, logit transformation is
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the log of the odds ratio, or the log of the proportion divided by one minus the
proportion (it can be done manually or using statistical software) (Fox, 2008).
The dependent variable (HIV testing) was a dichotomous mutually exclusive variable
(yes/no); therefore, the first assumption was met. The second assumption was also met
because there were several independent variables that were categorical and one
continuous variable.
To test independence of observations for categorical variables, I used the Fisher’s
exact test when appropriate (small sample size in the 2x2 cross tabulation), likelihood
ratio, and the Pearson Chi-Square. The independent categorical variables were analyzed
with the dependent variable (HIV testing) and with each other. The results showed only
two significant associations at p < .05; provider type and gender, and provider type and
experience. The connection between provider type and gender can be easily explained, as
well as provider type and experience. I checked for the presence of outliers for the
continuous variable using the Boxplot and the stem and leaf (Pallant, 2005), and there
were no outliers noted.
To test for linear relationship between any continuous independent variable and
the logit, I included in the model the interactions between the continuous predictor and its
log. As noted in Table 5, the Box-Tidwell transformed variable is not significant, hence
the linearity assumption was not violated. The Box-Tidwell test is a procedure used to
evaluate the assumption that the log odds are linearly related to the predictors, thus, in the
model, the interaction between each predictor and its natural log is included (Fox, 2008).
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Table 5
Box- Tidwell Test of Linearity Assumption
95% C.I. for EXP(B)
B
Age
Step
1

a

Age by
LnAge
Constant

S.E.

Wald

df

Sig.

Exp(B)

Lower

Upper

.320

1.123

.081

1

.776

1.377

.152

12.443

-.072

.235

.094

1

.759

.930

.587

1.474

-1.096

10.215

.012

1

.915

.334

The variables that were included in the regression model for the first research
question are presented in Table 6. In this table, the Wald test shows that none of the
variables in the model were significant at p = .05.
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Table 6
Summary of “Variables in the Model” for Research Question 1
B

Age

-.005

S.E.

Wald

.046

df

.014

Gender

Sig.

1

.906

.347

2

.841

Exp(B)

.995

95% C.I.for EXP(B)
Lower

Upper

.908

1.089

Gender
-22.237

40193.041

.000

1

1.000

.000

.000

.

-22.590

40193.041

.000

1

1.000

.000

.000

.

2.726

5

.742

(1)
Gender
(2)
Grad
Grad (1)

23.559

40193.083

.000

1

1.000

17043657170.137

.000

.

Grad (2)

23.590

40193.083

.000

1

1.000

17584988070.242

.000

.

Grad (3)

24.100

40193.083

.000

1

1.000

29274126626.929

.000

.

Grad (4)

23.521

40193.083

.000

1

1.000

16407691424.112

.000

.

Grad (5)

21.709

40193.083

.000

1

1.000

2678875887.412

.000

.

2.927

2

.231

Step 1a

Type
Type (1)

.108

.666

.026

1

.872

1.114

.302

4.104

Type (2)

1.425

.849

2.821

1

.093

4.159

.788

21.947

Constant

-.173

56841.738

.000

1

1.000

.841

a. Variable(s) entered on step 1: Age, Gender, Grad, Type.

To assess the overall fitness of the model, the Hosmer and Lemeshow test was used
(Hosmer & Lemeshow, 1989), and as shown in Table 7 it was not statistically significant
(p = .270), meaning that the model is a good fit.
Table 7
Hosmer and Lemeshow Test for Research Question 1
Step
1

Chi-square
9.933

df
8

Sig.
.270
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Table 8 shows the classification summary which denotes a moderately high
classification rate (75%), that is the overall percentage of how the model correctly
classifies cases. Additionally, the classification table provides the model’s sensitivity and
specificity; which is the percentage of the cases that had or did not have the observed
characteristic and were correctly predicted by the model. It can be noted from Table 8
that the specificity of the model was very high (98.4%) in accurately classifying events
that were true negatives (did not have the observed characteristics and were correctly
predicted), whereas its sensitivity in predicting cases that were true positives (had the
observed characteristics and were correctly predicted) was very low (16%).
Table 8
Classification Table for Research Question 1
Predicted
Observed

Have you ordered HIV test for

Percentage

your patient in the past 30 days?

Correct

yes

Step 1

no

Have you ordered HIV test for

yes

4

21

16.0

your patient in the past 30 days?

no

1

62

98.4

Overall Percentage
a.

75.0

The cut value is .500

To check the amount of variance in the dependent variable explained by the
model, I used the R-squared statistics as shown in Table 9. The R² in logistic regression is
referred to as Pseudo R² because it has lower values than in multiple regression (Field,
2013). Here it shows that only 12.7-18.2% of the variance in the dependent variable can
be explained by the model, which is low regardless of which R² is cited.
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Table 9
Model Summary for Research Question 1
Step
1

-2 Log

Cox & Snell R

Nagelkerke R

likelihood

Square

Square

93.069a

.127

.182

a. Estimation terminated at iteration number 20 because maximum
iterations has been reached. Final solution cannot be found.

In summary, a binomial logistic regression was performed to determine the effect
of provider type on the likelihood of ordering HIV test in the previous 30 days. None of
the predictors included in the model (including provider type) were statistically
significant. The model only explained 18.2% (Nagelkarke R²) of the variance and
correctly classified 75% of the cases. Therefore, the null hypothesis that there is no
relationship between HIV testing and provider type could not be rejected.
Research Question 2
Research Question 2: What is the relationship between HIV testing and providers’
knowledge, attitudes, and behaviors regarding HIV testing in the acute care setting?
H02: There is no relationship between HIV testing and providers’ knowledge,
attitudes, and behaviors regarding HIV testing in the acute care setting.
Ha2: There is a relationship between HIV testing and providers’ knowledge,
attitudes, and behaviors regarding HIV testing in the acute care setting.
In addition to the binomial logistic regression, I used the chi-square test for
association to analyze data for answering research question 2. There are three main
assumptions of the chi-square test for association (Laerd Statistics, 2013; Pallant, 2005):
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1. There should be two or more variables measured at categorical level.
2. Independence of observations.
3. All cells should have counts greater than five, and at least 80% of cells should
have expected frequencies of five or more.
The first two assumptions and their appropriateness were discussed and explained in the
previous section. The claim of independence of observations is based on mutually
exclusive observations that were not correlated; meaning that each case only contributed
data to one group without influencing others. The third assumption was also met, and it
will be demonstrated with each chi-square test. If the third assumption had not been met,
the Fisher’s exact test could have been used instead.
Tables 10, 11, and 12 show a summary of results from the chi-square tests for
associations when testing for the relationship between HIV testing and providers’
attitudes. In Table 10, there is a statistically significant association between HIV testing
and the belief that HIV testing will improve public health χ2(1) = 8.369, p = .004. The
strength of this relationship was drawn from Phi (Φ), and it indicated a moderately strong
association between HIV testing and providers’ belief that HIV testing will improve
public health φ = 0.308, p = .004. In Table 11, there is not a statistically significant
association between HIV testing and the belief that HIV testing will benefit patients χ2 (1)
= 3.281, p = .070. Table 12 shows that there is a statistically significant association
between HIV testing and the belief that testing will decrease providers’ ability to meet
other patients demands χ2 (1) = 8.213, p = .004. The strength of this association was
highlighted by the φ, that indicated a moderately strong association between not offering
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HIV testing and the belief that doing so will decrease providers’ ability to meet other
patients’ demands φ = 0.308, p = -.306.
Table 10
Chi-Square Analysis of HIV Testing Related to the Belief That Testing
Will Improve Public Health for Research Question 2
Value
Pearson ChiSquare
Continuity
Correctionb
Likelihood Ratio

df

Asymp. Sig.

Exact Sig. (2-

Exact Sig. (1-

(2-sided)

sided)

sided)

8.369a

1

.004

7.049

1

.008

8.896

1

.003

Fisher’s Exact
Test

.004

.003

N of Valid Cases 88
a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 11.08.
b. Computed only for a 2x2 table
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Table 11
Chi-Square Analysis of HIV Testing Related to the Belief That Testing
Will Benefit Patients for Research Question 2
Value
Pearson ChiSquare
Continuity
Correctionb
Likelihood Ratio

df

Asymp. Sig.

Exact Sig. (2-

Exact Sig. (1-

(2-sided)

sided)

sided)

3.281a

1

.070

2.473

1

.116

3.384

1

.066

Fisher’s Exact

.095

Test
N of Valid Cases

.057

88

a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 10.80.
b. Computed only for a 2x2 table

Table 12
Chi-Square Analysis of HIV Testing Related to the Belief That Testing Will Decrease
Provider Ability to Meet Other Patient Demands for Research Question 2
Value

Pearson Chi-Square
Continuity
Correctionb
Likelihood Ratio

8.213

a

Asymp. Sig.

Exact Sig. (2-

Exact Sig. (1-

(2-sided)

sided)

sided)

1

.004

6.723

1

.010

10.373

1

.001
.005

Fisher’s Exact Test
N of Valid Cases

df

.002

88

a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 6.25.
b. Computed only for a 2x2 table

Four factors were used to analyze the relationship between providers’ behaviors
and HIV testing in a binomial logistic regression: HIV testing policy, reimbursement, test
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type, and the estimation of local HIV prevalence. As shown in Table 13, none of these
factors were statistically significant at p = < .05 based on the outcome of the Wald test.
However, there was a statistically significant relationship between knowledge of CDC
testing recommendations and HIV testing (p = .026). The model was statistically
significant as indicated in Table 14 (p = .002). In Table 15, the model summary shows
that the amount of variance in the dependent variable explained by the model is 37.253.5% as evidenced by the R². To assess how well this model predicted categorical
outcomes, I conducted the Hosmer and Lemeshow test which was not statistically
significant (p = .540), meaning the model was a good fit (Table 16). The sensitivity of the
model which is the accuracy with which the model classifies cases as truly having the
observed characteristic was moderate at 64%, whereas its specificity was very good at
92.1% (Table 17). Overall, the addition of independent variables improved the model’s
capacity to predict and classify cases correctly to 84.1% (Table 17).
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Table 13
Summary of “Variables in the Model” for Research Question 2
B

S.E.

HIVprvlnc

df

Sig.

4.294

4

.368

Exp(B)

HIVprvlnc (1)

2.104

41447.738

.000

1

1.000

8.197

HIVprvlnc (2)

2.731

41447.738

.000

1

1.000

15.349

HIVprvlnc (3)

2.712

41447.738

.000

1

1.000

15.066

HIVprvlnc (4)

.985

41447.738

.000

1

1.000

2.677

4.661

4

.324

HIVPLCY
HIVPLCY (1)

-1.631

2.220

.540

1

.462

.196

HIVPLCY (2)

1.671

1.651

1.025

1

.311

5.319

HIVPLCY (3)

1.146

1.860

.379

1

.538

3.144

HIVPLCY (4)

3.676

41447.701

.000

1

1.000

39.480

.189

3

.979

TestType

Step 1a

Wald

TestType (1)

-21.875

10121.118

.000

1

.998

.000

TestType (2)

-21.463

10121.118

.000

1

.998

.000

TestType (3)

-17.683

62837.449

.000

1

1.000

.000

4.974

3

.174

CDCrcmnd
CDCrcmnd

25477.633

.000

1

.999

.849

.959

.784

1

.376

2.337

3.126

1.402

4.971

1

.026

22.779

7.974

4

.093

(1)
CDCrcmnd

9555855409.54

22.980

4

(3)
CDCrcmnd
(4)
Reimburse
Reimburse (1)

-22.926

26787.952

.000

1

.999

.000

Reimburse (2)

-18.947

26787.952

.000

1

.999

.000

Reimburse (3)

-21.228

26787.952

.000

1

.999

.000

Reimburse (4)

-19.663

26787.952

.000

1

.999

.000

Constant

37.740

48301.865

.000

1

.999

a. Variable(s) entered on step 1: HIVprvlnc, HIVPLCY, TestType, CDCrcmnd, Reimburse.

245736858698
48748.000
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Table 14
Omnibus Tests of Model Coefficients for Research Question 2

Chi-

df

Sig.

square
Step
Step 1

41.008

18

.002

Block 41.008

18

.002

18

.002

Mode
l

41.008

Table 15
Model Summary for Research Question 2
Step
1

-2 Log

Cox & Snell R

Nagelkerke R

likelihood

Square

Square

64.025a

.372

.535

a. Estimation terminated at iteration number 20
because maximum iterations has been reached. Final
solution cannot be found.

Table 16
Hosmer and Lemeshow Test for Research Question 2
Step

Chi-

df

Sig.

square
1

6.971

8

.540
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Table 17
Classification Table for Research Question 2
Predicted
Observed

Have you ordered HIV test for

Percentage

your patient in the past 30 days?

Correct

yes
Have you ordered

no

yes

16

9

64.0

no

5

58

92.1

HIV test for your
Step 1

patient in the past
30 days?
Overall Percentage

84.1

a. The cut value is .500

There was a statistically significant association between HIV testing and
providers’ attitudes toward HIV testing as measured by their beliefs. Therefore, the null
hypothesis that there was no relationship between providers’ attitudes and HIV testing
was rejected, and the alternative hypothesis was accepted. Similarly, there was a
statistically significant association between HIV testing and participants’ knowledge of
the CDC testing recommendations. Therefore, the null hypothesis that there was no
relationship between HIV testing and providers’ knowledge was rejected, and the
alternative hypothesis was accepted. However, there was no statistically significant
association between HIV testing and participants’ HIV testing behaviors, thus, the null
hypothesis that there is no relationship between HIV testing and providers’ testing
behaviors could not be rejected.
Research Question 3
Research Question 3: Is there a relationship between HIV testing and provideridentified barriers to it in the acute care setting?
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H03: There is no relationship between HIV testing and provider-identified barriers
to it in the acute care setting.
Ha3: There is a relationship between HIV testing and provider-identified barriers
to it in the acute care setting.
This hypothesis was also tested using the binomial logistic regression. A logistic
regression is a statistical test used to predict the probability that an observation will fall
into either category of a dichotomous dependent variable based on one or more predictive
variables (Field, 2013). The factors included in this model were barriers to HIV testing:
time, resources, re-imbursement, lack of experience, counselling, the consent process,
and providers’ perception of HIV risk among their patient population. In the analysis,
none of the variables were statistically significant at p = < .05 based on the Wald test.
Table 18 has the model summary which indicates that the variance explained by the
predictors was 55.5 to 79.7%, a rather strong test results. In Table 19, the classification
table shows an overall predictive accuracy of 92%. The model’s specificity was 98.4%,
whereas its sensitivity was 76% (Table 19), meaning that this model was effective at
predicting dichotomous outcomes based on the addition of independent variables. This
model was statistically significant as shown in Table 20 (χ2 (34) = 71.341, p < .001),
meaning that in terms of predicting HIV testing, the model containing independent
variables is a significant improvement over the model with just the constant.
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Table 18
Model Summary for Research Question 3
Step
1

-2 Log

Cox & Snell R

Nagelkerke R

likelihood

Square

Square

.555

.797

33.691a

a. Estimation terminated at iteration number 20 because maximum
iterations has been reached. Final solution cannot be found.

Table 19
Classification Table for Research Question 3
Predicted
Observed

Have you ordered

Have you ordered HIV test for

Percentage

your patient in the past 30 days?

Correct

yes

no

yes

16

6

76.0

no

1

62

98.4

HIV test for your
Step 1

patient in the past
30 days?

92.0

Overall Percentage
a. The cut value is .500

Table 20
Omnibus Tests of Model Coefficients for Research Question 3
Chi-

df

Sig.

square
Step
Step 1

71.341

34

.000

Block 71.341

34

.000

34

.000

Mode
l

71.341
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Because all variables were not statistically significant in this last model, there is
no statistically significant relationship between HIV testing and provider-identified
barriers to it in the acute care setting. Therefore, the null hypothesis could not be rejected.
Summary
I presented the results from statistical analyses that were performed related to the
research questions and hypotheses in Chapter 4. The sample N = 88 was drawn from a
population of clinicians who provided medical care to HIV negative patients in the acute
care setting. The primary data used in this analysis were collected from providers’
responses to a range of items in the survey questionnaire. The effect of several predictors
on a single outcome variable (HIV testing) was measured. I used the binomial logistic
regression and the chi-square test for association to examine the relationship between the
dependent variable and independent variables.
For the first research question, the null hypothesis that there is no relationship
between HIV testing and provider type could not be rejected. For the second research
question, the alternative hypotheses that there is a relationship between providers’
attitudes, knowledge and HIV testing were accepted. However, the null hypothesis that
there is no relationship between HIV testing and providers’ behaviors could not be
rejected. In the third research question, the null hypothesis that there is no relationship
between HIV testing and provider-identified barriers to it in the acute care setting could
not be rejected. Chapter 5 includes: an interpretation of the results, discussion,
recommendations, and the social change implications of the study.
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Chapter 5: Interpretation, Discussion, Conclusion
The purpose of this quantitative study was to examine the relationships between
HIV testing and provider type, knowledge, attitudes, and behaviors regarding HIV testing
in the acute care setting. I also examined the relationship between provider-identified
barriers to HIV testing and HIV testing in the acute care setting. Additionally, I examined
providers’ age, gender, race/ethnicity, and experience to determine whether they had any
effect on the offering of HIV testing. After I analyzed the data using two statistical tests, I
found no significant associations between HIV testing and provider type, age, gender,
race/ethnicity, experience, barriers, and behaviors. However, I found significant
associations between HIV testing and providers’ attitudes and knowledge of CDC testing
recommendations.
Interpretation of the Findings
Based on the study’s findings, I concluded that there was a general lack of routine
HIV testing in the providers’ practices. Routine HIV testing per the CDC
recommendations is nontargeted HIV testing using the opt-out approach in all patients
ages 13 to 64- in healthcare settings. Most participants (69.3%) in the study conducted
targeted HIV testing based on patients’ risk factors or symptoms. The lack of routine HIV
testing was highlighted by the finding that more than two thirds of providers (71.6%) did
not order an HIV test in the previous 30 days, and almost half (47.7%) did not order an
HIV test in the previous 6 months. These findings are consistent with those of other
researchers who indicated that many providers conduct targeted HIV testing
(Christopoulos et al., 2011; Lubelcheck et al., 2011; Schrantz et al., 2011), and that
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routine HIV testing is underutilized (Anaya et al., 2012; Arbelaez et al., 2012; Egan et al.,
2014; Herrin et al., 2013; Tai & Merchant, 2014). A close look at the study site showed
that in the previous 12 months 23,268 patients between the ages 13 and 64 were
discharged home after receiving medical care, but only 131 HIV tests were ordered in
that same period. Based on these findings, it appears that there were missed opportunities
for HIV testing in the study site similar to what previous researchers have found (Klein et
al., 2014; Nakao et al., 2014).
Previous studies have indicated mixed results regarding the influence of provider
type on the offering of HIV testing. McNaghten et al. (2013) and Fincher-Mergi et al.
(2002) found that compared to physicians, NPs were more likely to order HIV testing,
although Bender Ignacio et al. (2014) observed that compared to physicians, NPs and
PAs were less likely to order HIV testing on patients. In the current study, I did not find a
statistically significant association between HIV testing and provider type. McNaghten et
al. obtained data from a nationwide outpatient provider survey, Bender Ignacio et al. used
data from a community-based urgent clinic linked to Massachusetts General Hospital,
and data for the current study came from a survey of acute care providers in a single
facility. Therefore, the differences in these studies’ findings may be due to differences in
data sources.
In addition to examining the impact of provider type on HIV testing, other
researchers explored the differences in the offering of HIV testing between various
medical specialties. Bernstein et al. (2008) and McNaghten et al. (2013) observed some
associations between HIV testing and providers’ clinical specialty. However, in the

110
current study, there was no statistically significant association between HIV testing and
providers’ clinical specialty. In the current study, however, most participants specialized
in internal and family medicine, that might explain why the findings from the current
study differed from previous studies regarding the relationship between HIV testing and
providers’ clinical specialty.
Previous research has shown that many patients received initial HIV diagnosis in
ED, where large number of patients presented to ED having already developed AIDS
(Copeland et al., 2012; Nakao et al., 2014). Many patients had several encounters with
ED providers before they finally got tested for HIV infection (Nakao et al., 2014).
Previous studies have shown suboptimal performance of HIV testing by obstetricians and
gynecologists (Levison et al., 2012), and declining testing rates in primary care settings
and EDs since the CDC recommendations were established (Tai & Merchant, 2014).
Providers in ED, internal medicine, and primary care are the clinicians who have initial
encounters with most patients at health care centers. Therefore, researchers need to
examine how these providers approach HIV testing and other factors related to their
practices that might impede HIV testing.
Previous studies have indicated that positive attitudes and beliefs among providers
about HIV testing are associated with increased likelihood of offering HIV testing
(Akhter et al., 2012; Berkenblit et al., 2012), whereas negative or neutral attitudes and
beliefs about HIV testing are associated with limited HIV testing and lack of support for
HIV testing services among providers (Arbelaez et al., 2012; Conway et al., 2015; Hsieh
et al., 2009; Nassry et al., 2012; Sison et al., 2013). In agreement with these studies, I
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found in this study that providers who had positive attitudes and beliefs about HIV testing
were more likely to order HIV test, and providers who had negative attitudes about HIV
testing were less likely to order HIV test. Perhaps a change in the policies related to HIV
testing, coupled with training programs for providers would foster positive attitudes
among providers which might increase HIV testing. Hsieh et al. (2009) found that a
focused training program on HIV testing in the ED led to favorable provider attitudes and
perceptions, and increased HIV testing.
Like findings from previous studies (Arya et al., 2013; Hunter et al., 2012;
Levison et al., 2012), the results from the current study indicated that knowledge of the
CDC guidelines for HIV testing was low among participants. Almost half of providers in
the current study (49%) were not aware of the CDC recommendations for HIV testing.
Shirreffs et al. (2012) found that although 77% of providers in their study were aware of
the CDC testing recommendations, only 5% implemented them. Furthermore, the
findings from the current study agreed with those of Lanier et al. (2014) and Meanley et
al. (2015) that participants who were knowledgeable regarding the CDC
recommendations for HIV testing were more likely to order the HIV test on patients.
Previous research indicated that lack of reimbursement and perception of low
prevalence of local HIV infection were related to lack of HIV testing, whereas
established HIV testing policies and training were linked with the likelihood of offering
HIV testing (Akhter et al., 2012; Berkenblit et al., 2012; Messer et al., 2013). In the
current study, there were no significant associations between HIV testing and providers’
perception of the local HIV prevalence, reimbursement concerns, availability of testing
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programs, the type of test used, or personal approach to HIV testing. It is possible that
these factors have a certain degree of influence on the offering of HIV testing as cited by
some individual participants; however, their cumulative impact did not reach statistical
significance.
Several barriers have been identified by previous researchers as likely obstacles to
HIV testing in healthcare centers. Provider-specific barriers include resource constraints
such as inadequate staffing and test kits (Egan et al., 2014; Houkoos et al., 2013), time
constraints (Kinsler et al., 2013; Korthuis et al., 2011), lack of knowledge related to HIV
testing guidelines, discomfort discussing sexual matters with patients, and attitudes and
beliefs toward HIV testing (Hunter et al., 2012; Kinsler et al., 2013; Korthuis et al., 2011;
Lanier et al., 2014; Levison et al., 2012). Although the findings in this study were not
statistically significant regarding HIV testing barriers, 54% of participants indicated that
the consent process was too burdensome, 53% indicated that pretest counseling was time
consuming and burdensome, 65% indicated that the risk of HIV infection was low among
their patients, 26% indicated that they did not have enough time to conduct HIV tests,
and 46% indicated they did not have adequate resources. These findings seem to agree
with those of previous studies regarding provider-related barriers to HIV testing
(Korthuis et al., 2011; Rizza, McGowan, Purcell, Branson, & Temesgen 2012; Shirreffs
et al., 2012). Although use of the written consent and pretest HIV counseling have been
eliminated from the HIV testing guidelines to facilitate HIV testing, findings in the
current study were congruent with previous studies, indicating that many providers cited
these barriers as possible obstacles to HIV testing (Korthuis et al., 2011; Rizza et al.,
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2012; Shirreffs et al., 2012). It is possible that the lack of significant findings regarding
the effect of provider-identified barriers on HIV testing in the current study was due to
insufficient sample size.
When providers in the current study were asked about the revised IAC
recommendations related to HIV testing, 65% correctly indicated that IAC requires
informed consent for HIV testing, 54% incorrectly indicated that IAC requires a written
consent for HIV testing, 47% incorrectly indicated that IAC requires posttest prevention
counseling for all patients, 51% correctly indicated that IAC requires documentation of a
pregnant patient’s refusal of HIV testing, and 55% indicated correctly that IAC requires
opt-out HIV testing. Additionally, 50% of providers indicated that the IAC changes were
likely to increase HIV testing in their practices. However, there were no statistically
significant associations between HIV testing and provider beliefs or knowledge regarding
IAC changes. It is evident that many providers are not aware of the IAC
recommendations for HIV testing, and those who are aware do not offer HIV testing.
Findings from the current study did not indicate a statistically significant
association between gender and HIV testing. Previous research indicated that female
providers were more likely to screen patients for HIV (Arbelaez et al., 2012; Hsieh et al.,
2009). However, there is a lack of clarity in the previous literature concerning the
relationship between gender and HIV testing. Bernstein et al. (2008) noted that gender
was not significant in ED-based HIV testing, but female providers in pediatric,
emergency, and internal medicine practices were more likely to offer HIV testing in the
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acute care setting compared to general or family practitioners. Few studies addressed the
role of gender with regards to HIV testing in health care settings.
The current study did not indicate any significant association between providers’
years of work-related experience and HIV testing. Hsieh et al. (2009) found that residents
with 2 or more years of experience were less likely to offer HIV testing than residents
who had 2 or fewer years of work-related experience. Furthermore, Conway et al. (2015)
indicated that providers who practiced in HIV-based clinics were more likely to offer
rapid point of care HIV testing than those who had no experience providing medical care
to HIV-infected patients. However, the findings from these two studies were based on
data from different countries, populations, and settings; thus, consensus is lacking.
Limited research on the role of race/ethnicity in HIV testing could be located.
Two studies indicated that providers of African American and Hispanic descent were
more likely to offer HIV testing than those from other ethnic groups (Bernstein et al.,
2008; McNaghten et al., 2013). The current study, however, did not indicate a statistically
significant association between providers’ race/ethnicity and HIV testing. Additionally,
the current study did not indicate any statistically significant association between
providers’ age and HIV testing. Although Bernstein et al. (2008) and McNaghten et al.
(2013) found that emergency department providers who were younger than 40 had a
higher probability of offering HIV testing than older emergency providers. The
differences in the findings between the current study and previous studies regarding the
effect of providers’ age and race/ethnicity on HIV testing could be due to small sample
size of minority participants in the current study. Further research is needed to clarify
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whether there is any influence of providers’ gender, age, work experience, and
race/ethnicity on HIV testing.
The relationship between infection with HIV and other STDs has been established
in the literature, showing greater likelihood of coinfection with HIV among those
infected with STDs and vice versa (Fleming & Wasserrheit, 1999; Saxton, Garnett, &
Rottingen, 2005). Klein et al. (2014) found that there were low rates of concurrent
HIV/STD testing in academic ED settings. Moreover, many patients who used ED
services shared several risk factors for HIV/STD infection (Pringle et al., 2013), but
patients underestimated their risk profile, perhaps hindering HIV testing especially
among providers who order HIV test based on patient risk profile (Clause et al., 2011;
Nunn et al., 2011; Pringle et al., 2013; Setse & Maxwell, 2014). Although most providers
in the current study indicated that they had inquired about IDU (83%), MSM (69.3%),
pregnancy (54.5%), number of sexual partners and condom use (72.7%), STD history
(83%), and history of Hepatitis C or B (54.5%) among their patients, their offering of
HIV testing to patients did not reflect concerns regarding patients’ risk profiles. The
importance of concurrent HIV/STD testing may need to be emphasized among providers
in the acute care setting to increase the overall testing rates, especially among patients
who present with STDs.
The findings in the current study led to the conclusion that knowledge of HIV
testing recommendations and positive attitudes and beliefs about HIV testing among
providers in the acute care setting are significantly associated with HIV testing. These
findings were consistent with what previous researchers found (Akhter et al., 2012;

116
Berkenblit et al., 2012). Additionally, there were no significant relationships between
HIV testing and provider type, gender, age, experience, specialty, and behaviors in this
study. Furthermore, the impact of provider-identified barriers on HIV testing did not
reach statistical significance in this study. Previous research yielded mixed results
regarding the influence of provider characteristics and structural barriers on HIV testing
in the acute care setting.
Although many of the independent variables in this study were not significantly
related to the outcome variable, there were some variables that had p-values that were
close to being significant. However, wide confidence intervals suggested low precision of
the odds ratios (OR). Low precision and wide confidence intervals would be attributed to
insufficient sample size. Although most independent variables were not significantly
related to the outcome variable, it does not mean the findings had no clinical relevance.
Statistical significance only provides information necessary to accept or reject a null
hypothesis; it does not provide information on the effect size. The findings in this study
have clinical importance despite some parts that lacked statistical significance. For
example, provider-identified barriers have an impact on HIV testing despite not achieving
statistical significance.
SCT provided the theoretical framework under which the current study was
undertaken. Theory enables researchers to explore phenomena contextually and broadly,
and it plays an essential role in explaining the relationships among research variables
(Tavallaei & Abu Talib, 2010). At the core of the SCT is the premise that behavior and
knowledge are acquired and maintained through complex interaction between personal,
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behavioral, and environmental factors. Key findings from the current study mirrored
some of the SCT concepts and highlighted how personal, behavioral, and environmental
(type of HIV test, ED resources including staffing, and policies) factors interacted with
HIV testing in the acute care setting.
The findings from the current study indicated that participants with positive
attitudes and belief about HIV testing were more likely to order HIV test among their
patients. This coincided with the SCT concept of self-efficacy perception which stipulates
that individuals’ behaviors and performances are linked to their self-efficacy perceptions,
the value they place on the task at hand and its relevancy to the community at large. In
the HIV testing landscape, the role of theory was advanced by Schnall et al. (2013), who
noted that among ED providers in two New York City hospitals, those with higher selfefficacy perceptions were more likely to offer HIV testing. Another key finding in the
current study associated with the likelihood of offering HIV testing, was providers’
knowledge of HIV testing guidelines. Behavioral capability per Bandura (1977) is the
attainment of knowledge and skills necessary to develop and maintain effective
behaviors. Therefore, HIV testing is affected by several factors, and knowledge of HIV
testing guidelines is one such factor. Furthermore, findings from the current study support
the influence of behavioral and environmental factors on HIV testing in the acute care
setting. The lack of routine HIV testing in the acute care setting as noted in the current
study can be addressed by considering two of the SCT concepts; incentive/motivation and
collective efficacy. Some providers indicated that lack of reimbursement and other
resources precluded HIV testing in their practices. It is possible that incentivizing acute
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care providers and increasing reimbursement related to HIV testing might lead to higher
testing rates. Additionally, measures to get all stakeholders involved (providers,
administrators, leadership, and ancillary staff), coupled with changing the infrastructure
surrounding HIV testing are some of the steps that could promote buy-in and perceived
collective efficacy (shared belief in the collective effort for the good of the community)
(Bandura, 1986). Providers who see that their behaviors have impact on the performance
of their organization, and on the wellbeing of the entire community are likely to adopt
behavior changes necessary to uphold the common good. A strong theoretical foundation
is essential when examining the practice of HIV testing, and for the research related to
HIV testing behaviors. It is imperative to incorporate predictive and explanatory aspects
of theory when designing programs and implementing measures aimed at changing
health-related behaviors (Glanz et al., 2008; Sales, Smith, Curran, & Kochever, 2006)
Limitations of the Study
The findings from this study should be viewed with caution given some
limitations that may have affected its internal validity. The first limitation is the sample
size that may not have been large enough. Even though the sample size was in line with
the required sample size for statistical analysis as determined a priori using the G-Power
software, it may not have been sufficient. The second limitation is the use of a
nonprobability sampling method. The sampling approach may have led to the sample
being non-representative, and that could have reduced the external validity of the study.
Furthermore, selection bias would have been the reason for having a small sample of
participants from minority groups such as African Americans, Asians, and Hispanics. The
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third limitation of this study was the utilization of the cross-sectional design. Using the
cross-sectional design makes it difficult to determine cause and effect; because the
exposure and the outcome of interest are measured simultaneously. Therefore, utility of
the cross-sectional design limits generalizability of the results. The fourth limitation was
the use of a self-report instrument. There is potential for recall bias whenever a selfreport instrument is used, and that presents an internal validity threat. In this study, I used
an established instrument which was already pilot-tested which might have mitigated the
limitation associated with self-report instrument. The fifth limitation arose from resource
and time constraints. Due to resource and time constraints, I was compelled to use the
cross-sectional design and the nonprobability sampling method. Additionally, I could not
afford to give participants any incentives to encourage participation and higher response
rate. The effect of maturation is the sixth limitation that might have caused an internal
validity threat to the study. Participants in this study were just finishing up a huge
facility-based survey that was conducted by an outside agency right before I conducted
my survey. Therefore, participants may have experienced fatigue and exhaustion due to
being asked to engage in back to back surveys. In addition, being an employee in the
same facility as the participants may have had some influence on validity, given that
some of the providers might have known me as a co-worker. Thus, this possibly
introduced the Hawthorne effect; participants’ responses might have been influenced by
knowledge of being known to the researcher, and this represents an internal validity
threat.
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Recommendations
The current study yielded important information that I used to make two types of
recommendations: recommendations for future studies, and recommendations related to
the current practice of HIV testing.
1. Future research is needed to determine whether there is a significant
association between HIV testing and provider type. Current literature is
inconclusive, and in the current study there was no significant association
found between provider type and HIV testing.
2. Future research is needed to determine whether provider age, gender,
experience, and/or race/ethnicity have any impact on HIV testing in the acute
care setting. Current literature shows mixed results, and in this study, no
significant relationship was found.
3.

It is worthwhile for future researchers to fully explore the impact of providerrelated barriers on HIV testing, and how those barriers interact with patientspecific barriers in the healthcare setting.

To the facility that was the primary source of data and participants for the current
study, following are the recommendations regarding the practice of HIV testing:
1. Testing for HIV should be conducted throughout the inpatient and ED areas
until the local prevalence can be established. This will give the medical
providers with a clear basis to conduct routine HIV testing as recommended
by the CDC.
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2. The facility should adopt various educational and training measures to
increase knowledge of both the CDC and IAC testing guidelines among its
providers, and to bolster positive provider attitudes related to the practice of
HIV testing.
3. A range of policy measures that could promote HIV testing should be
considered including: utility of ancillary staff such as nurses to perform HIV
testing, thus removing the burden of decision-making related to HIV testing
from providers (Egan et al., 2014; Klein et al., 2014), adoption of rapid point
of care HIV testing in ED; a policy with potential to increase testing,
availability of results at the time of services, and timely referral (Lubelchek et
al., 2011; Pottie et al., 2014), and implementation of electronic reminders and
other automated strategies that have shown great success in increasing HIV
testing without adding significant burden to an already limited resources
enterprise (Gaydos et al., 2013; Goetz et al., 2009).
4. Establish a system-wide task force to address all provider-identified barriers to
HIV testing, because this might be an expeditious pathway to achieving
increased HIV testing.
To achieve robust outcomes in future research that can address the problem of HIV
testing in the acute care setting, limitations of the current study must be overcome using
several strategies. First, it will be paramount to replicate this study using a larger sample
size to boost its power. Secondly, the use of probability sampling methods is strongly
advised to mitigate validity threats. Another crucial recommendation that could produce

122
more generalizable results is to conduct similar studies using participants from several
locations and/ or facilities. Finally, strategies to increase participation of minority racial
and ethnic providers, such as African Americans and Hispanics, will boost the capacity to
answer many questions surrounding the lack of HIV testing in the acute care setting.
Implications for Social Change
HIV infection and AIDS continue to have tremendous impact on the health and
wellbeing of many people both locally and globally. There are socio-economic,
morbidity, and mortality consequences associated with HIV/AIDS. In the United States,
approximately 1.2 million people were living with HIV in 2012, and another 156,300lacked knowledge of being infected with HIV (CDC, 2015a). Although there have been
some gains made over the years in curtailing HIV incidence and mortality, HIV remains
the 8th leading cause of death among individuals ages 25 to 34, and the 9th leading cause
of death among individuals ages 35 to 44 (CDC, 2016h). The numbers of new HIV
infections have remained steady at about 50,000 per year since the 1990s (CDC, 2012;
Hall, 2008). Many public health officials are concerned that the new HIV infections
continue to occur because of many individuals who are not aware of being infected with
HIV.
In response to a modest decline in the number of new HIV infections over the
years (CDC, 2012; Hall, 2008), and the lack of routine HIV testing, the CDC established
new HIV testing guidelines that were aimed at increasing HIV testing in healthcare
settings by removing many barriers. The CDC guidelines were adopted by many agencies
and states and were aimed at promoting routine non-targeted HIV testing in all patients
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ages 13 to 64 in healthcare centers (Branson et al., 2006). There is no cure for HIV
infection or AIDS. Prevention is the best option to ward off this deadly virus. More
importantly, HIV testing is the only way to identify those who may be infected. Earlier
diagnosis of HIV infection can lead to timely initiation of HAART and entry into many
therapeutic programs, both of which are associated with slowing the development of
AIDS and promoting higher quality of life for those infected (Deeks, Lewin, & Havlir,
2013). More importantly, changes in risky sexual behaviors have been noted among
people who learn that they are infected with HIV (Marks et al., 2005).
The information and data collected from the current study could be applied in
several ways to promote positive social change. The findings indicated that there was
lack of routine HIV testing in the study setting. Given that the study setting is in an area
where local HIV prevalence exceeds the recommended threshold for non-targeted routine
HIV testing, it is imperative for policies that promote HIV testing to be instituted.
Undiagnosed HIV infection is linked to almost 50% of people infected with HIV that are
not on antiretroviral therapy (Woodring et al., 2015). Additionally, the findings of the
current study showed that many providers lacked knowledge of the CDC testing
guidelines. Therefore, providers continued to conduct targeted HIV testing and some
failed to perform HIV testing in many occasions. However, among participants in this
study, knowledge of CDC testing guidelines was associated with the offering of HIV
testing. Findings from this study also indicated that positive attitudes and beliefs about
HIV testing were associated with HIV testing. To increase HIV testing, especially in the
ED environment, measures to increase awareness are needed including educating
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providers on the importance of conducting HIV testing. Lastly, the findings included
several barriers identified by providers that hinder HIV testing. Elimination of these
barriers as well as mitigating perceived barriers among providers might be a good place
to target efforts aimed at promoting HIV testing.
If adopted, the recommendations from the findings of this study have potential to
spur robust HIV testing in the acute care setting. The potential positive social change of
this study is to lead to increased HIV testing and screening in the acute care setting,
especially when the local HIV prevalence exceeds the threshold recommended for routine
testing by the CDC. Greater HIV testing in the acute care setting can reduce the number
of people who lack knowledge of having HIV infection.
The National HIV/AIDS Strategy (NHAS) has three main goals:
1. Reduce HIV incidence.
2. Eliminate HIV/AIDS-related disparities.
3. Increase access to HIV care. (Office of National Aids Policy, 2010).
To achieve these and many other goals related to the prevention of HIV/AIDS, several
measures should be considered including the recommendations from this study. The
current study was conducted to examine factors that influence HIV testing in the acute
care setting. By pointing out the lack of routine HIV testing, highlighting possible
barriers to HIV testing, and proposing several recommendations, the findings from this
study could result in increased HIV testing in the acute care setting. Increased HIV could
lead to prompt HIV diagnosis and possibly timely entry into treatment programs. More
importantly, reducing unawareness of HIV infection, having more people with HIV
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infection stay through the treatment course, achieving desirable viral load, and ultimately
mitigating the transmission of HIV infection are essential public health goals to pursue.
Conclusion
The purpose for conducting this study was to examine whether provider-identified
barriers, demographics factors, personal characteristics, and clinical infrastructure have
any impact on the offering of HIV testing in the acute care setting. The findings from this
study showed several factors that could be contributing to the lack of routine HIV testing
in the study setting. Additionally, the findings showed that knowledge of the CDC testing
guidelines and positive attitudes about HIV testing are associated with offering HIV test.
However, contrary to what some researchers have found in the past, the current study did
not find any statistically significant associations between HIV testing and providers’ age,
gender, experience, race/ethnicity, and HIV testing barriers. The findings from this study
pointed to the need for more research to gain firm understanding of how various factors
influence HIV testing in the acute care setting.
In addition to providing data on provider-related factors that influence HIV
testing in this cross-sectional study, I highlighted other policy-related factors that are
instrumental in an environment where HIV testing is lacking. The findings also led to the
development of several recommendations that have potential to spur increased HIV
testing in the acute care settings, and perhaps lead to a reduction of seropositive status
unawareness. Priority should be given to any measures and future research that would
decelerate the spread of HIV/AIDS. Thus, acute care settings and providers who work
there represent prime areas where efforts to routinize HIV testing should be focused.
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Appendix A: Permission to Use the ‘PHSKC HIV Testing Survey: Knowledge, Attitudes
and Practices’ Questionnaire
Alexandra Shirreffs <Alexandra.Shirreffs@phila.gov>
To Ariri Alex Aug 31 at 1:08 PM
Hi Alex,
Sure – if you end up publishing anything I’d just ask that you cite our paper
appropriately. Do you need a copy of the questionnaire? The copy I had disappeared
from my work computer but I probably have it on a hard drive at home.
Best of luck!
Alex
-----------------------------------------------------------Alex Shirreffs, MPH
Viral Hepatitis Prevention Coordinator (VHPC)
215-685-6462 * alexandra.shirreffs@phila.gov
www.phillyhepatitis.org
www.hepcap.org
www.hepbunited.org

156
Appendix B: Permission to Use the SGIM Questionnaire
Sarann Bielavitz <bielavit@ohsu.edu>
To Ariri Alex Aug 17 at 3:28 PM
Hi, Alex:
I spoke with Dr. Korthuis today, and he said you are welcome to use the questionnaire.
I’ve attached the survey here.
Sarann
Sarann Bielavitz
Senior Research Assistant
Department of Internal Medicine
Oregon Health & Science University
Phone: 503-418-1944
Fax: 503-494-0979
Sarann Bielavitz <bielavit@ohsu.edu>
To Ariri Alex Aug 24 at 4:55 PM
Yes, the questions can be edited as-needed.
Sarann
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Appendix C: Survey Questionnaire
Testing HIV in Acute Care Setting (THACS): Providers’ Impact.
Medical providers (Nurse Practitioners, Physician Assistants, and Physicians) who
provide regular care to HIV negative patients (ages 13-64 years) are invited to be part of
this research study about the practice of HIV testing in the acute care setting. This form is
part of a process called “informed consent” to allow you to understand this study before
deciding whether to take part.
This study is being conducted by a researcher named Alex Ariri who is a doctoral student
at Walden University. You might also know the researcher as a nurse practitioner, but
this study is separate from that role.
The purpose of this study is to examine the impact providers’ characteristics have in the
performance of HIV testing in the acute care setting.
If you agree to be in this study, you will be asked to:
• Complete the survey questionnaire
• The survey questionnaire will take approximately 10-15 minutes.
This study is voluntary. Everyone will respect your decision of whether you choose to be
in the study or not. No one at Presence St. Joseph Medical Center will treat you
differently if you decide not to be in the study. If you decide to join the study now, you
can still change your mind later. You may stop at any time. Please note that all providers
except those in psychiatric department will be offered the opportunity to participate in
this study.
Being in this type of study involves some risk of the minor discomforts that can be
encountered in daily life, such as becoming upset, however, being in this study would not
pose risk to your safety or wellbeing. While there might not be direct benefits to you as a
participant, this study could contribute knowledge that might help reduce HIV positive
unawareness, and thus the prevention of HIV transmissions which is important to the
larger community.
There are no payments or compensation for participating in this study. Any information
you provide will be kept confidential. This is an anonymous survey and no identifying
personal information such as your name that is collected. The researcher will not use your
personal information for any purposes outside of this research project, and data will be
kept for a period of at least 5 years, as required by the university.
You may ask any questions you have now. Or if you have questions later, you may
contact the researcher via: alex.ariri@waldenu.edu, or 815-519-0417. If you want to talk
privately about your rights as a participant, you can call Dr. Leilani Endicott, her phone
number is 612-312-1210, she is the Walden University representative who can discuss
this with you. The IRB approval number for this study is 07-08-16-0342839 and it
expires on July 7th 2017. Please print or save this consent form for your records, and if
you feel you understand the study well enough to decide about it, please indicate your
consent by completing the survey.
SECTION 1: ELIGIBILITY QUESTIONS
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The following series of questions will determine your eligibility to participate in this
survey.
Eligibility Q1 and Q2
1. Do you regularly provide direct patient care to HIV-negative individuals between the
ages of 13 and 64 years old? (Required)
a. Yes
b. No
2. Are you a doctor, physician’s assistant, or nurse practitioner with authority to order
HIV tests at your practice? (Required)
a. Yes
b. No
SECTION 2: PRACTICE & KNOWLEDGE QUESTIONS
This series of questions will help the researcher – understand the HIV testing practices of
local providers and assess their knowledge of HIV testing guidelines recommended by
the U.S. Centers for Disease Control and Prevention (CDC) and the HIV testing rules
outlined in the Illinois Administrative Code (IAC).
3. Is there an HIV testing policy at your primary work location?
a. Yes, routine testing*
b. Yes, targeted testing based on a patient’s risk factors
c. No, my practice does not have a HIV testing policy
d. HIV testing is prohibited in my practice
e. I don’t know
f. Other (please specify)
4. Which of these describe how you personally approach HIV testing with your patients
(check all that apply)?
a. I test all my adolescent and adult patients at their first visit
b. I test patients who report HIV risk factors
c. I test patients who have signs or symptoms of HIV/AIDS.
d. I test any patient who asks for an HIV test
e. I never order HIV tests
*Per the CDC, “‘Routine counseling and testing’ is defined as a policy to provide these
services to all clients after informing them that testing will be done. Except where testing
is required by law, individuals have the right to decline to be tested without being denied
health care or other services.”
5. In the past SIX MONTHS, approximately how many times did you personally order an
HIV test?
a. None
b. 1 to 5
c. 6 to 10
d. 11 to 24
e. 25 or more
6. In the past TWELVE MONTHS approximately how many patients did you diagnose as
HIV positive?
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a. None in the past year1
b. 2 to 5 individuals
c. 6 or more individuals
d. I have never in my career newly diagnosed a patient with HIV infection
7. Have you ordered any HIV tests for your patients in the past 30 days?
a. Yes
b. No
Beliefs About HIV Testing
8. I estimate the prevalence of HIV-infection in the population my clinic serves are:
a. < 0.1%
b. 0.1%-0.9%
c. 1.0% - 4.9%
d. 5.0% - 10%
e. > 10%
9. I believe offering HIV testing to all people’s age 13-64 regardless of risk will improve
public health in my community.
a. Yes
b. No
10. I believe offering routine HIV testing to all patients regardless of risk will benefit my
patients.
a. Yes
b. No
11. I believe offering routine HIV testing to all patients regardless of risk will decrease
my ability to meet their other medical needs.
a. Yes
b. No
Barriers to Testing
Please rate how strongly you agree or disagree with the statements below regarding
factors that prevent you from offering routine HIV screening in your practice and/or limit
the number of tests that you can do:
12. There are many reasons why providers may not offer routine HIV screening in their
practices.
• Nothing, I conduct routine HIV testing for all adolescent and adult patients:
Strongly disagree: Disagree: Agree: Strongly agree: Undecided
• I do not have enough time to conduct HIV tests
Strongly disagree: Disagree: Agree: Strongly agree: Undecided
• I think that the consent process for HIV testing is too time consuming and/or
burdensome.
Strongly disagree: Disagree: Agree: Strongly agree: Undecided
• I think that pre-test or risk reduction counseling is too time consuming and/or
burdensome.
Strongly disagree: Disagree: Agree: Strongly agree: Undecided
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•

I do not have enough experience providing pre-test or risk reduction counseling.
Strongly disagree: Disagree: Agree: Strongly agree: Undecided
• I do not understand the legal procedures or implications associated with HIV
testing (e.g. reporting HIV-positive cases or counseling requirements).
Strongly disagree: Disagree: Agree: Strongly agree: Undecided
• I do not have resources to assure an HIV positive diagnosis will occur smoothly
with appropriate follow-up.
Strongly disagree: Disagree: Agree: Strongly agree: Undecided
• I am concerned about reimbursement.
Strongly disagree: Disagree: Agree: Strongly agree: Undecided
• I am concerned I cannot provide enough information for questions the patient
might have about HIV testing.
Strongly disagree: Disagree: Agree: Strongly agree: Undecided
• I am concerned about language barriers.
Strongly disagree: Disagree: Agree: Strongly agree: Undecided
• I do not feel comfortable discussing HIV, sex behaviors, or drug use with my
patients. Strongly disagree: Disagree: Agree: Strongly agree: Undecided
• I do not think my patients would feel comfortable discussing HIV, sex behaviors,
or drug use with me.
Strongly disagree: Disagree: Agree: Strongly agree: Undecided
• I do not have a private space to do testing.
Strongly disagree: Disagree: Agree: Strongly agree: Undecided
• I think the risk of HIV among my patient population is low.
Strongly disagree: Disagree: Agree: Strongly agree: Undecided
• HIV testing is prohibited in my practice.
Strongly disagree: Disagree: Agree: Strongly agree: Undecided
Please specify any other reasons why you do not conduct routine HIV testing in your
practice.
-------------------------------------------CDC Knowledge
In September 2006, CDC released its Revised Recommendations for HIV Testing of
Adults, Adolescents, and Pregnant Women in Health-Care Settings. These
recommendations were released to increase the proportion of HIV-infected persons who
are aware of their HIV status. The following question will help us understand how
familiar you are with the CDC recommendations.
13. Check one answer that best reflects the CDC’s recommendations:
a. Test all patients between 13-64 years of age for HIV, regardless of risk factor history
b. Test all patients for HIV if the prevalence of HIV in your community is greater than
.1%
c. Test those patients who report HIV risk factors
d. Test those patients who display signs or symptoms of AIDS
e. All the above
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IAC Knowledge
The following questions will help us understand how familiar you are with the Illinois
Administrative Codes (IAC) rules for HIV testing, counseling, and partner services.
These rules were recently changed in May 4th, 2012.
14. Please answer the following True/False questions about the current IAC rules:
• The IAC requires informed consent for HIV testing.
Strongly disagree: Disagree: Agree: Strongly agree: Undecided
• The IAC requires written consent for HIV testing.
Strongly disagree: Disagree: Agree: Strongly agree: Undecided
• The IAC requires providers to offer posttest prevention counseling to all patients.
Strongly disagree: Disagree: Agree: Strongly agree: Undecided
• The IAC requires providers to document a pregnant patient’s refusal of an HIV
test. Strongly disagree: Disagree: Agree: Strongly agree: Undecided
• The IAC requires opt-out testing. *
Strongly disagree: Disagree: Agree: Strongly agree: Undecided
* The CDC defines opt-out screening as “performing HIV screening after notifying the
patient that 1) the test will be performed and 2) the patient may elect to decline or defer
testing. Assent is inferred unless the patient declines testing.”
15. The Illinois Administrative Code (IAC) changed in May 2012 to align more closely
with the CDC’s 2006 HIV Testing Guidelines. Providers will not be required to conduct
detailed pretest counseling but they will still be required to inform patients when an HIV
test is being conducted, giving patients the option to decline or “opt-out.”
• Will these changes increase your HIV testing practices?
Strongly disagree: Disagree: Agree: Strongly agree: Undecided
Risk Factor Screening questions
16. Which of the following information do you routinely collect to assess a patient’s risk
of infection with the HIV or Hepatitis viruses?
Country of Birth: Y/N
History of Injection Drug use: Y/N
History of methamphetamine or stimulants use: Y/N
For men, whether they have ever had sex with another man: Y/N
For women, pregnancy history: Y/N
For men and women, number of recent sexual partners and use of condoms: Y/N
STD history: Y/N
History of Hepatitis C, B: Y/N
History of blood transfusion or organ transplant prior to 1985: Y/N
17. Which HIV tests do you use for HIV screening (check all that apply)?
a. Standard HIV antibody tests on blood
b. Rapid HIV antibody tests: finger prick or oral fluids
c. Pooled HIV RNA testing
d. HIV RNA testing for symptomatic persons
e. We do not offer HIV testing at my practice
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18. Have you attended any meeting, lectures, or other information sessions regarding
HIV testing
within the last 12 months?
a. Yes
b. No
Demographic: Zip/Provider type
Section 3: Demographic Questions
19. What is the ZIP code of the primary practice location where you provide direct
patient care?
______________
20. I am a:
a. Nurse Practitioner
b. Physician Assistant
c. M.D or D.O
21. What year did you complete training (residency and/or fellowship)? ________
22. Check one box that best describes your primary clinical specialty:
a. Emergency Medicine
b. Family Medicine
c. Geriatrics
d. Internal Medicine
e. Obstetrics/Gynecology
f. Pediatrics
g. Surgery
h. Other: Specify
23. Check the boxes that apply to the main sub-specialties you practice:
a. Infectious Disease
b. Sexually transmitted diseases, not including HIV
c. HIV
d. Other (please specify)
24. Check the box(es) that best describes the work setting(s) where you provide direct
patient care:
a. Ambulatory Clinic or Office
b. Hospital – Inpatient
c. Hospital – Emergency Room
d. Hospital – Outpatient
c. Other (please specify)
25. What is your gender?
a. Male
b. Female
c. Transgender
26. What is your Age? __________
27. Are you of Spanish/Hispanic/Latino origin? Y/N
28. What do you consider your race to be?
a. White
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b. Black/African-American
c. Native American/Alaskan Native
d. Asian
e. Pacific Islander/Hawaiian Native
f. Other (please specify)

